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???????ls ??? ????????? All chemicals and solvents were purchased from ABCR, ACROS,
ALFA–AESAR, APOLLO SCIENTIFIC, FLUKA, FLUOROCHEM, MERCK, SIGMA-ALDRICH, TCI, or STREM 
CHEMICALS and used as received, unless mentioned otherwise.1 Et2O and THF were 
distilled from Mg/anthracene, CH2Cl2 and EtOAc from CaH2, toluene from Na/K, and 
MeOH from Mg turnings under an inert atmosphere of nitrogen or argon. DMF, DMSO, 
MeCN, Et3N and pyridine were dried by passage through molecular sieve colums (H2O 
content < 30 ppm, KARL–FISCHER titration) using a VACUUM ATMOSPHERES COMPANY Solvent 
Purifier system.2 Dry acetone was obtained by drying over B2O3, followed by filtration 
and distillation.3 2,6-Lutidine was distilled from CaH2 under an inert atmosphere of 
argon. [(Cp*)RuCl2]n was prepared according to a literature procedure.4 Copper(I) 
thiophene-2-carboxylate (CuTC) could either be prepared according to a literature 
procedure5 or purchased from SIGMA-ALDRICH without noticeable differences in 
reactivity. (Bu4N)OP(O)Ph2 was prepared by a slightly adapted procedure (vide infra).6 
All hygroscopic or air-sensitive chemicals were stored in SCHLENK-flasks under an 
atmosphere of argon at the appropriate temperature, as indicated by the supplier. 
??????l ??????????? All non-aqueous reactions were performed under an inert
atmosphere of dry argon at ca. 0.4 bar overpressure using flame dried glassware, unless 
otherwise noted. Reactions were stirred using magnetic stir-bars and monitored by thin 
layer chromatography (TLC). Analytical thin layer chromatography was performed using 
MACHEREY–NAGEL POLYGRAM SIL G/UV pre-coated polyester plates and visualized by 
ultraviolet light (UV). Additionally, TLC plates were stained with either aqueous 
potassium permanganate [1.5 g KMnO4, 200 mL H2O, 10 g K2CO3, 2.5 mL 1M NaOH aq.], 
cerium ammonium molybdate [0.5 g Ce(NH4)2(NO3)6, 12 g (NH4)6Mo7O24·4H2O, 235 mL 
H2O, 15 mL conc. H2SO4] or ethanolic p-anisaldehyde [3.7 mL p-anisaldehyde, 135 mL 
EtOH, 5 mL conc. H2SO4, 1.5 mL AcOH]. Concentration under reduced pressure (= in 
vacuo) was performed using commercial rotator evaporators. Chromatographic 
1 For general information on purification of chemicals and reagents, see: W. L. F. Armarego, C. L. L. Chai, 
Purification of Laboratory Chemicals, 7th ed., Elsevier, Amsterdam, ????.
2 A. B. Pangborn, M. A. Giardello, R. H. Grubbs, R. K. Rosen, F. J. Timmers, Organometallics ????, 15, 1518-1520.
3 D. R. Burfield, R. H. Smithers, J. Org. Chem. ????, 43, 3966-3968.
4 T. D. Tilley, R. H. Grubbs, J. E. Bercaw, Organometallics ????, 3, 274-278.
5 G. D. Allred, L. S. Liebeskind, J. Am. Chem. Soc. ????, 118, 2748-2749.
6 For the original procedure, see: J. Srogl, G. D. Allred, L. S. Liebeskind, J. Am. Chem. Soc. ????, 119, 12376-12377.?
purification was performed as flash chromatography7 on MERCK 60 Å (40-63 µm) silica 
gel at ca. 0.4 bar overpressure. Purified compounds were dried under high vacuum 
(10−3 mbar).  
????????al ???????? Nuclear Magnetic Resonance (NMR): NMR data were recorded on a 
BRUKER AV 400 (Progeny cryoprobe) or BRUKER AVIII 600 (cryoprobe) spectrometer in 
the solvents indicated. Chemical shifts (δ) are reported in ppm with the residual solvent 
signal as internal standard (CDCl3 at 7.26 and 77.00 ppm for 1H and 13C NMR 
spectroscopy, respectively; CD3OD at 3.31 and 49.00 ppm for 1H and 13C NMR 
spectroscopy, respectively), unless otherwise noted. 1H NMR data are reported as δ 
(ppm) (s = singlet, d = doublet, t = triplet, q = quartet, qui = quintet, m = multiplet or 
unresolved, br = broad signal, app. = appearing as; coupling constant(s) (J) in Hz; 
integration). 13C NMR spectra were recorded with broadband 1H decoupling while 
J-coupling(s) to other NMR-active heteronuclei (i.e. 19F and 31P) are reported as (d = 
doublet, t = triplet, q = quartet, qui = quintet; coupling constant(s) in Hz). If HSQC or 
DEPT data were available the carbon atoms are denoted with (CH3 = methyl, CH2 = 
methylene, CH = methine, CR4 = fully substituted carbon atom). 31P NMR and 119Sn NMR 
spectra were referenced to H3PO4 (85% in D2O) and SnMe4, respectively, as external 
standards.  
Only experimentally observed and resolved signals are tabulated or compiled; therefore it is 
possible that the number of signals in the 13C NMR spectra does not match the expected 
number of magnetically inequivalent C-atoms in a given molecule. 
Fourier Transform Infrared Spectrometry (FTIR): FTIR spectra were recorded on a 
PERKIN ELMER Spectrum One FT-IR (UATR) instrument as thin films. Absorptions (ν) are 
given in wavenumbers (cm–1). 
High Resolution Mass Spectrometry (HRMS): HRMS analyses were performed as ESI 
measurements on a BRUKER 7T APEX III Fourier Transform Ion Cyclotron MS or a FINNIGAN 
MAT 95 instrument. 
??W. C. Still, M. Kahn, A. Mitra, J. Org. Chem. ????, 43, 2923-2925.?
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??????n?????????????m ???????????????????. To a suspension of Ph2PO2H (5.50 g, 
25.2 mmol) in dry MeOH (27.5 mL) at ambient temperature was added Bu4NOH (1.0 M 
in MeOH, 25.2 mL, 25.2 mmol) and the resulting yellow solution was stirred at that 
temperature for another 15 min. The mixture was filtered through a short pad of Celite, 
eluting with dry MeOH (25 mL), and the combined filtrates were concentrated under 
reduced pressure (water bath at 60 °C). The resulting pale yellow oil was dried under 
high vacuum for 8 h to afford a solid yellow wax, which was re-dissolved in dry EtOAc 
and the solvent evaporated again to remove residual MeOH. Recrystallization of the 
residue from EtOAc/Et2O (ca. 1:4, 50 mL; slow cooling from reflux to –20 °C) afforded 
Ph2PO2NBu4 (10.6 g, 92%) as white crystalline needles. 1H NMR (400 MHz, CDCl3): 
δ 7.92-7.85 (m, 4H), 7.27-7.18 (m, 6H), 3.31 (app. t, J = 8.4 Hz, 8H), 1.57 (app. quintet, J = 
7.9 Hz, 8H), 1.35 (sextet, J = 7.4 Hz, 8H), 0.92 (app. t, J = 7.3 Hz, 12H); 13C NMR (101 MHz, 
CDCl3): δ 131.7 (d, J = 8.6 Hz), 128.3 (br s), 127.2 (d, J = 11.3 Hz), 58.9 (s), 24.2 (s), 19.7 
(s), 13.7 (s); 31P NMR (162 MHz, CDCl3, 1H-decoupled): δ 13.14. 
8 a) S. M. Rummelt, K. Radkowski, D.-A. Roşca, A. Fürstner, J. Am. Chem. Soc. ????, 137, 5506-5519; b) D.-A.
Roşca, K. Radkowski, L. M. Wolf, M. Wagh, R. Goddard, W. Thiel, A. Furstner, J. Am. Chem. Soc. ????, 139, 2443- 
2455; c) H. Sommer, A. Fürstner, Chem. Eur. J. ????, 23, 558-562; d) H. Sommer, A. Fürstner, Org. Lett. ????, 18, 




?????????????????????? nBuLi, (1.6 M in hexanes, 21.5 mL, 34.4 mmol) was added to a 
solution of 1-hexyne (4.80 mL, 41.8 mmol) in THF (90 mL) at 0 °C and the resulting 
mixture was stirred at that temperature for 30 min. 3-Phenylpropanal (3.60 mL, 
27.3 mmol) was added and the resulting mixture was allowed to reach ambient 
temperature over 2 hours. The reaction was quenched by the addition of NH4Cl solution 
(50 mL, sat. aqueous) and the aqueous phase was extracted with tert-butyl methyl ether 
(3 × 100 mL). The combined extracts were dried over Na2SO4, filtered and concentrated 
under reduced pressure. Purification of the residue by flash chromatography 
(EtOAc/hexane 15:85) afforded the title compound (5.62 g, 99%) as a colorless oil. 
1H NMR (400 MHz, CDCl3): δ 7.32-7.27 (m, 2H), 7.24-7.17 (m, 3H), 4.37 (tt, J = 6.5, 2.0 Hz, 
1H), 2.80 (t, J = 7.9 Hz, 2H), 2.24 (td, J = 7.0, 2.0 Hz, 2H), 2.07-1.93 (m, 2H), 1.84 (br s, 
1H), 1.55-1.39 (m, 4H), 0.94 (t, J = 7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ 141.5 (CR4), 
128.5 (2 × CH2), 128.4 (2 × CH2), 125.9 (CH), 86.0 (CR4), 80.9 (CR4), 62.0 (CH), 39.7 (CH2), 
31.5 (CH2), 30.7 (CH2), 21.9 (CH2), 18.3 (CH2), 13.6 (CH3); FTIR (thin film): ν 3334, 3063, 
3027, 2955, 2931, 2862, 2229, 1604, 1496, 1455, 1379, 1328, 1133, 1053, 1030, 915, 




???????????????????????????? HBr (48% in H2O, 0.05 mL, 0.4 mmol, 10 mol%) and 2-
octynal (500 mg, 4.03 mmol) were successively added to a suspension of Sn powder 
(717 mg, 6.04 mmol) and 2,3-dibromopropene, 80 wt% (1.50 mL, 12.3 mmol) in Et2O 
(8.0 mL) and H2O (8.0 mL). The resulting mixture was stirred for 6 h before it was 
diluted with tert-butyl methyl ether (50 mL) and poured into H2O (50 mL). The aqueous 
phase was extracted with tert-butyl methyl ether (2 × 50 mL), the combined organic 
layers were dried over Na2SO4, filtered and concentrated under reduced pressure. 
Purification of the residue by flash chromatography (EtOAc/hexane 10:90 to 20:80; step 
gradient) afforded the title compound (792 mg, 97%) as a colorless oil. 1H NMR (400 
??
?
MHz, CDCl3): δ 5.74 (dt, J = 2.0, 1.1 Hz, 1H), 5.55 (d, J = 1.7 Hz, 1H), 4.68 (ddt, J = 7.6, 5.5, 
2.0 Hz, 1H), 2.81 (ddd, J = 14.5, 7.7, 0.9 Hz, 1H), 2.75 (ddd, J = 14.5, 5.6, 1.2 Hz, 1H), 2.20 
(td, J = 7.1, 2.0 Hz, 2H), 1.83 (s, 1H), 1.54-1.46 (m, 2H), 1.39-1.26 (m, 4H), 0.90 (app. t, J = 
7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ 128.7 (CR4), 120.2 (CH2), 86.7 (CR4), 79.5 (CR4), 
60.6 (CH), 49.9 (CH2), 31.0 (CH2), 28.2 (CH2), 22.2 (CH2), 18.6 (CH2), 14.0 (CH3); FTIR 
(thin film): ν 3339, 2957, 2932, 2860, 2230, 1632, 1459, 1429, 1341, 1202, 1145, 1116, 
1037, 890 cm−1; HRMS (ESI): exact mass calculated for C11H17O(79Br)Na [(M+Na)+] 




?Z???????????????????????????????????????????? Bu3SnH (3.75 mL, 13.9 mmol) was 
added dropwise over 1 h via syringe pump to a brown solution of 1-phenylnon-4-yn-3-ol 
(2.60 g, 12.0 mmol) and [(Cp*)RuCl2]n (110 mg, 0.358 mmol, 3 mol%) in CH2Cl2 (60 mL) 
at ambient temperature. The mixture was stirred for additional 0.5 h before it was 
concentrated under reduced pressure. Purification of the residue by flash 
chromatography (EtOAc/hexane 5:95 to 10:90; step gradient) afforded the title 
compound (5.62 g, 92%) as a faintly yellowish oil with a proximal/distal ratio of >99:1. 
1H NMR (400 MHz, CDCl3): δ 7.31-7.26 (m, 2H), 7.22-7.17 (m, 3H), 6.18 (td, J = 7.2, 1.1 Hz, 
1H), 4.15 (t, J = 6.8 Hz, 1H), 2.65 (qdd, J = 13.8, 9.8, 6.2 Hz, 2H), 2.05 (app. q, J = 7.2 Hz, 
2H), 189-1.66 (m, 2H), 1.60-1.41 (m, 7H), 1.41-1.25 (m, 10H), 1.04-0.82 (m, 18H); 
13C NMR (101 MHz, CDCl3): δ 147.5 (CR4), 142.2 (CR4), 141.2 (CH), 128.5 (2 × CH), 128.3 
(2 × CH), 125.7 (CH), 79.4 (CH), 39.3 (CH2), 34.0 (CH2), 32.3 (2 × CH2), 29.3 (3 × CH2), 
27.4 (3 × CH2), 22.6 (CH2), 14.1 (CH3), 13.7 (3 × CH3), 11.1 (3 × CH2); 119Sn NMR 
(149 MHz, CDCl3, 1H decoupling): δ −55.1; FTIR (thin film): ν 3463, 3063, 3027, 2955, 
2922, 2871, 2853, 1614, 1496, 1455, 1419, 1376, 1340, 1289, 1180, 1152, 1071, 1048, 
1030, 1001, 961, 925, 863, 767 cm−1; HRMS (ESI): exact mass calculated for C27H48OSnNa 





?Z?????????????????????????????????????????????????? Bu3SnH (1.20 mL, 4.46 mmol) 
was added over 1 h via syringe pump to a dark brown solution of 2-bromoundec-1-en-5-
yn-4-ol (973 mg, 3.97 mmol) and [(Cp*)RuCl2]n (36.0 mg, 0.117 mmol, 3 mol%) in CH2Cl2 
(20 mL) at ambient temperature. The resulting mixture was stirred for additional 0.5 h 
before it was concentrated under reduced pressure. Purification of the residue by flash 
chromatography (EtOAc/hexane 2:98 to 5:95 to 10:90; step gradient) afforded the title 
compound (1.62 g, 76%) as colorless oil with a proximal/distal ratio of 92:8. 1H NMR 
(400 MHz, CDCl3): δ 6.27 (td, J = 7.2, 1.1 Hz, 1H), 5.65 (d, J = 1.3 Hz, 1H), 5.51 (d, J = 1.6 
Hz, 1H), 4.50-4.46 (m, 1H), 2.57- 2.47 (m, 2H), 2.05-1.98 (m, 2H), 1.69 (d, J = 2.8 Hz, 1H), 
1.55-1.42 (m, 6H), 1.39-1.24 (m, 12H), 1.01-0.95 (m, 6H), 0.89 (t, J = 7.3 Hz, 12H); 
13C NMR (101 MHz, CDCl3): δ 145.5 (CR4), 141.7 (CH), 130.8 (CR4), 119.3 (CH2), 76.4 
(CH), 49.9 (CH2), 34.3 (CH2), 31.7 (CH2), 29.7 (CH2), 29.2 (3 × CH2), 27.4 (3 × CH2), 22.6 
(CH2) , 14.0 (CH3), 13.7 (3 × CH3), 11.1 (3 × CH2; 119Sn NMR (149 MHz, CDCl3, 1H 
decoupling): δ −54.0; FTIR (thin film): ν 3463, 2955, 2922, 2871, 2854, 1630, 1493, 
1463, 1420, 1376, 1290, 1197, 1147, 1116, 1071, 1020, 961, 883, 745, 698 cm−1; HRMS 
(ESI): exact mass calculated for C23H45OBrSnNa [(M+Na)+] 559.1567, found 559.1563. 
 
 
?E??????????????????????? ???? CuTC (20.0 mg, 105 µmol) was added to a solution of 
(Z)-1-phenyl-4-(tributylstannyl)non-4-en-3-ol (?) (50.0 mg, 98.5 µmol) and Ph2PO2NBu4 
(50.0 mg, 109 µmol) in DMF (0.50 mL) at ambient temperature and the resulting mixture 
was stirred for 2.5 h. The mixture was diluted with tert-butyl methyl ether (30 mL) and 
poured into a mixture of 25% aqueous NH4OH/sat. aqueous NH4Cl solution (1:9, 10 mL). 
The phases were separated and the aqueous layer extracted with tert-butyl methyl ether 
(2 × 30 mL). The combined organic extracts were dried over Na2SO4, filtered and 
concentrated under reduced pressure. Purification of the residue by flash 
??
?
chromatography (EtOAc/hexane 20:80) afforded the title compound (20.8 mg, 97%) as 
colorless oil. 1H NMR (400 MHz, CDCl3): δ 7.31-7.25 (m, 2H), 7.22-7.17 (m, 3H), 5.66 (dtd, 
J = 15.4, 6.7, 0.9 Hz, 1H), 5.50 (ddt, J = 15.4, 7.0, 1.4 Hz, 1H), 4.08 (q, J = 6.7 Hz, 1H), 2.76-
2.63 (m, 2H), 2.05 (q, J = 6.6 Hz, 2H), 1.93-1.76 (m, 2H), 1.46 (br s, 1H), 1.41- 1.26 (m, 
4H), 0.90 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ 142.0 (CR4), 132.7 (CH), 132.6 
(CH), 128.4 (2 × CH), 128.3 (2 × CH), 125.8 (CH), 72.5 (CH), 38.8 (CH2), 31.9 (CH2), 31.8 
(CH2), 31.3 (CH2), 22.2 (CH2), 13.9 (CH3); FTIR (thin film): ν 3358, 3063, 3027, 2956, 
2926, 2858, 1603, 1496, 1455, 1379, 1294, 1098, 1053, 1030, 970, 917, 746 cm−1; HRMS 
(ESI): exact mass calculated for C15H22ONa [(M+Na)+] 241.1563, found 241.1564. 
?????????????? ???????re ??r ??? ????????????????????n ????g A????????????. (Z????
???????????????????????????????????????????. Diethoxymethyl-
silane (650 mg, 4.8417 mmol) was added under argon to a stirred 
solution of 1-phenyldec-4-yn-3-ol (950 mg, 4.3916 mmol) and 
[Cp*RuCl]4 (60 mg, 0.05520 mmol) in CH2Cl2 (22 mL). Once the reaction was complete 
(ca. 15 min, TLC), CNCH2COOK (120 mg, 0.97 mmol) was added as catalyst scavenger, 
and stirring was continued for 2 hours. Insoluble matrials were filtered off and rinsed 
with CH2Cl2, the combined filtrates were evaporated under reduced pressure, and the 
residue was purified by filtration through a short pad of silica using hexanes/ethyl 
acetate 15:1 as the eluent to give the title compound as a pale yellow oil (942 mg, 61 %). 
1H NMR (400 MHz, CDCl3) δ 7.30-7.25 (m, 2H), 7.21-7.15 (m, 3H), 6.12 (t, J = 7.6 Hz, 1H), 
3.95 (m, 1H), 3.80 (m, 4H), 3.49 (d, J = 10.3 Hz, OH), 2.77-2.56 (m, 2H), 2.27-2.16 (m, 2H), 
2.06-1.95 (m, 1H), 1.87-1.76 (m, 1H), 1.43-1.29 (m, 4H), 1.24 (td, J = 5.0, 0.9 Hz, 6H), 0.91 
(m, 3H), 0.28 (s, 3H); 13C (101 MHz, CDCl3) δ 146.8, 142.5, 138.2, 128.4, 125.6, 79.6, 58.3, 
40.5, 32.8, 31.8, 31.3, 22.5, 18.18, 18.13, 14.0, -2.1; FTIR (thin film): ṽ 3496, 3026, 2958, 
2926, 2874, 1613, 1496, 1481, 1454, 1410, 1390, 1364, 1294, 1257, 1214, 1165, 1101, 
1071, 1031, 1006, 945, 876, 817, 792, 760, 698 cm-1; HRMS (ESI): exact mass calculated 
for C20H34O3SiNa (M+Na+) 373.2169, found 373.2173. 
?Z??????????????????????????????????????????????????????????????. Prepared 
analogously as a colorless oil (115 mg, 36 %). 1H NMR (400 MHz, 
CDCl3) δ 7.31-7.25 (m, 2H), 7.21-7.15 (m, 3H), 6.05 (t, J = 7.5 Hz, 
??
?
1H), 3.98 (m, 1H), 3.80 (m, 4H), 3.31 (d, J = 9.8 Hz, OH), 2.79-2.57 (m, 2H), 2.44-2.31 (m, 
4H), 2.05-1.93 (m, 1H), 1.87-1.70 (m, 3H), 1.25 (td, J = 5.0, 0.9 Hz, 6H), 0.29 (s, 3H); 13C 
(101 MHz, CDCl3) δ 142.7, 142.1, 141.3, 128.4, 125.7, 119.3, 78.9, 58.3, 40.1, 32.6, 30.2, 
25.4, 18.13, 18.11, 16.7, -2.2; FTIR (thin film): ṽ 3493, 3026, 2972, 2926, 2246, 1615, 
1496, 1454, 1424, 1390, 1365, 1293, 1259, 1164, 1101, 1069, 947, 792, 758, 699 cm-1; 
HRMS (ESI): exact mass calculated for C20H31NO3SiNa [(M+Na)+] 384.1965, found 
384.1966. 
????l ??E??Z???????????????????????????????????????????????????????????????. 
Prepared analogously as a pale yellow oil (207 mg, 65 %). 1H NMR 
(400 MHz, CDCl3) δ 6.25 (t, J = 7.6 Hz, 1H), 6.05 (t, J = 1.4 Hz, 1H), 
4.42 (d, J = 10.0 Hz, 1H), 4.16 (q, J = 7.2 Hz, 2H), 4.10 (d, J = 9.8 Hz, 
OH), 3.82-3.70 (m, 4H), 2.26 (m, 2H), 2.03 (s, 3H), 1.44-1.30 (m, 4H), 1.27 (t, J = 7.1 Hz, 
3H), 1.23 (td, J = 7.0, 0.9 Hz, 6H), 0.91 (m, 3H), 0.20 (s, 3H); 13C (101 MHz, CDCl3) δ 167.1, 
159.8, 150.1, 134.9, 114.6, 83.1, 59.5, 58.5, 31.7, 31.3, 22.5, 18.0, 16.3, 14.3, 14.0, -2.4; 
FTIR (thin film): ṽ 3466, 2973, 2926, 2875, 1716, 1651, 1612, 1443, 1390, 1366, 1342, 
1258, 1207, 1142, 1100, 1071, 1044, 948, 876, 821, 801, 762, 681 cm-1; HRMS (ESI): 
exact mass calculated for C18H34O5SiNa [(M+Na)+] 381.2068, found 381.2068. 
?Z???????????????????????????????????????????????????????????????. Prepared 
analogously as a pale yellow oil (164 mg, 47 %). 1H NMR (400 MHz, 
CDCl3) δ 6.54 (s, 1H), 5.75 (m, 1H), 4.24 (m, 1H), 3.85-3.74 (m, 5H), 2.06 
(m, 2H), 2.00 (m, 2H), 1.68-1.50 (m, 4H), 1.36 (d, J = 6.6 Hz, 3H), 1.24 (m, 
6H), 0.24 (s, 3H); 13C (101 MHz, CDCl3) δ 147.0, 139.5, 136.6, 126.6, 75.5, 58.3, 58.2, 28.1, 
25.4, 24.7, 22.5, 21.9, 18.1, -2.5; FTIR (thin film): ṽ 3448, 2971, 2925, 2833, 1597, 1438, 
1390, 1364, 1294, 1255, 1164, 1102, 1070, 942, 895, 859, 838, 797, 756, 730, 684 cm-1; 
HRMS (ESI): exact mass calculated for C15H28O3SiNa [(M+Na)+] 307.1700, found 
307.1702. 
?Z??????????????????????????????????????????????????????????? Prepared 
analogously as a colorless oil (180 mg, 90 %). 1H NMR (400 MHz, 
CDCl3) δ 7.31-7.25 (m, 2H), 7.21-7.15 (m, 3H), 6.21 (t, J = 7.5 Hz, 1H), 
4.32 (s, OH), 3.77 (m, 4H), 2.69 (m, 2H), 2.54 (m, 2H), 1.35 (s, 6H), 
1.23 (t, J = 6.8 Hz, 6H), 0.22 (s, 3H); 13C (101 MHz, CDCl3) δ 143.9, 141.5, 140.7, 128.5, 
??
?
128.3, 125.9, 74.0, 58.2, 36.1, 33.2, 30.1, 18.1, -1.9; FTIR (thin film): ṽ 3497, 3086, 3063, 
3027, 2972, 2926, 2883, 1605, 1496, 1482, 1454, 1390, 1369, 1294, 1258, 1209, 1163, 
1100, 1069, 998, 944, 881, 790, 752, 698 cm-1; HRMS (ESI): exact mass calculated for 
C18H30O3SiNa [(M+Na)+] 345.1856, found 345.1857. 
?Z???????????????????????????????????????????????????????????????????????????? 
Prepared analogously as a yellow oil that has to be used without 
delay  (118 mg, 88 %). 1H NMR (400 MHz, CDCl3) δ 10.00 (s, 1H), 
7.83 (m, 2H), 7.47 (m, 2H), 7.31 (s, 1H), 4.44 (s, OH), 3.72 (m, 4H), 
1.49 (s, 6H), 1.16 (t, J = 7.0 Hz, 6H), -0.05 (s, 3H); 13C (101 MHz, CDCl3) δ 191.8, 150.8, 
145.6, 139.9, 135.2, 129.31, 129.16, 74.9, 58.4, 30.5, 18.0, -2.0; FTIR (thin film): ṽ 3483, 
2973, 2927, 2884, 2838, 2733, 1697, 1602, 1565, 1482, 1443, 1389, 1363, 1305, 1260, 
1208, 1166, 1102, 1067, 949, 889, 866, 813, 794, 777, 758, 688 cm-1; HRMS (ESI): exact 
mass calculated for C17H26O4SiNa [(M+Na)+] 345.1493, found 345.1495. 
 




?????????????? ???????re ??? ??? ????????????n ?? ????????????????? ?????? ? 
????????????????m ?????????????: ?E???????????????????????????????l ???? To a 
clear, colorless solution of (Z)-1-phenyl-4-(tributylstannyl)non-4-en-3-ol (?) 
(254 mg, 501 µmol) and (Ph2PO2)NBu4 (250 mg, 544 µmol) in DMF (2.5 mL) at 
ambient temperature was added Pd(PPh3)4 (30.0 mg, 26 µmol, 5 mol%) and the 
resulting yellow mixture was stirred until complete dissolution had occurred, 
usually ca. 5 min. After that time, MeI (48 µL, 770 µmol) was added, immediately 
followed, within max. 30 seconds, by CuTC (100 mg, 524 µmol). The resulting black 
suspension was stirred for 0.5 h before the reaction was quenched by the addition 
??
?
of Et3N (ca. 0.1 mL). The mixture was diluted with tert-butyl methyl ether (30 mL), 
poured on a mixture of 25% aqueous NH4OH/sat. aqueous NH4Cl solution (1:9, 
20 mL), the phases were separated and the bright blue aqueous phase extracted 
with tert-butyl methyl ether (2 × 30 mL). The combined organic extracts were 
dried over Na2SO4, filtered and concentrated under reduced pressure. Purification 
of the residue by flash chromatography (EtOAc/hexane 10:90 to 20:80; step 
gradient) afforded the methylated product ? (107 mg, 92%) as a faintly yellowish 
oil with a methylation/protodestannation ratio of ?:? = 97:3, as determined by 1H 
NMR and GCMS. 1H NMR (400 MHz, CDCl3): δ 7.32-7.25 (m, 2H), 7.23-7.16 (m, 3H), 
5.41 (t, J = 7.1 Hz, 1H), 4.02 (t, J = 6.7 Hz, 1H), 2.71-2.55 (m, 2H), 2.04 (q, J = 7.0 Hz, 
2H), 1.95-1.79 (m, 2H), 1.63 (s, 3H), 1.46 (br s, 1H), 1.40-1.26 (m, 4H), 0.91 (app. t, 
J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ 142.1 (CR4), 136.7 (CR4), 128.4 
(2 × CH), 128.3 (2 × CH), 127.3 (CH), 125.7 (CH), 77.4 (CH), 36.5 (CH2), 32.2 (CH2), 
31.7 (CH2), 27.2 (CH2), 22.4 (CH2), 14.0 (CH3), 11.2 (CH3); FTIR (thin film): ν 3348, 
3027, 2955, 2927, 2858, 1496, 1455, 1378, 1298, 1052, 1030, 998, 918, 851, 747, 





?????????????? ???????re ??r ??? ??????????n ?f ????????????????. ?????? B 
???TC ?????? ?E???????????????????????????????l ???. To a clear, colorless 
solution of (Z)-1-phenyl-4-(tributylstannyl)non-4-en-3-ol (?) (254 mg, 501 µmol) 
and (Ph2PO2)NBu4 (250 mg, 544 µmol) in DMSO (2.5 mL) at ambient temperature 
was added MeI (95 µL, 1500 µmol), immediately followed, within maximum 30 
seconds, by CuTC (100 mg, 524 µmol). The resulting black suspension was stirred 
for 1 hour before the reaction was quenched by the addition of Et3N (ca. 0.1 mL). 
??
?
The mixture was diluted with tert-butyl methyl ether (30 mL) and poured on a 
mixture of 25% aqueous NH4OH/sat. aqueous NH4Cl solution (1:9, 20 mL). The 
phases were separated and the clear, bright blue aqueous phase was extracted 
with tert-butyl methyl ether (2 × 30 mL). The combined organic extracts were 
dried over Na2SO4, filtered and concentrated under reduced pressure. Purification 
of the residue by flash chromatography (EtOAc/hexane 10:90 to 20:80; step 
gradient) afforded the desired methylated product ? (99.4 mg, 85%) as a colorless 
oil with a methylation/protodestannation ratio ?:? = 99:1, as determined by 1H 
NMR and GCMS. Analytical and spectral data as described above. 
?E????????????????????????????????????? Prepared according to method ? as a 
colorless oil (78.2 mg, 76%) with a methylation/protodestannation 
ratio of 94:6, as determined by 1H NMR and GCMS.  
The same product was prepared according to method ? as a colorless 
oil (89.8 mg, 88%) with a methylation/protodestannation ratio of 79:21, as determined 
by 1H NMR and GCMS. 1H NMR (400 MHz, CDCl3): δ 7.33-7.27 (m, 2H), 7.24-7.18 (m, 3H), 
5.58 (td, J = 7.1, 1.3 Hz, 1H), 2.71 (dd, J = 8.8, 6.8 Hz, 2H), 2.36 (app. q, J = 7.4 Hz, 2H), 1.63 
(br s, 4H), 1.33 (s, 6H); 13C NMR (101 MHz, CDCl3): δ 142.1 (CR4), 141.9 (CR4), 128.4 
(2 × CH), 128.1 (2 × CH), 125.6 (CH), 121.1 (CH), 73.3 (CR4), 35.8 (CH2), 29.8 (CH2), 28.8 
(2 × CH3), 12.6 (CH3); FTIR (thin film): ν 3384, 3026, 2974, 2927, 2858, 1603, 1496, 
1453, 1370, 1258, 1136, 1075, 1030, 1001, 935, 850, 746, 697 cm–1; HRMS (ESI): exact 
mass calculated for C14H20ONa [(M+Na)+] 227.1406, found 227.1404. 
??E??E??????????????????????????????? Prepared according to method ? as a colorless 
oil (65.8 mg, 72%) with a methylation/protodestannation ratio 
of 95:5, as determined by 1H NMR and GCMS. 1H NMR (400 MHz, 
CDCl3): δ 5.72 (dtd, J = 15.4, 6.3, 1.2 Hz, 1H), 5.46 (ddt, J = 15.4, 
6.8, 1.5 Hz, 2H), 4.45 (d, J = 6.5 Hz, 1H), 2.13-1.98 (m, 4H), 1.59 (s, 3H), 1.56 (br s, 1H), 
1.39-1.24 (m, 4H), 0.99 (t, J = 7.5 Hz, 3H), 0.89 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, 
CDCl3): δ 136.3 (CR4), 133.9 (CH), 130.0 (CH), 126.3 (CH), 78.2 (CH), 31.7 (CH2), 27.3 
(CH2), 25.3 (CH2), 22.4 (CH2), 14.0 (CH3), 13.4 (CH3), 12.1 (CH3); FTIR (thin film): ν 3352, 
??
?
2959, 2926, 2872, 2857, 1459, 1378, 1297, 1084, 1004, 965, 850 cm−1; HRMS (ESI): exact 
mass calculated for C12H22ONa [(M+Na)+] 205.1563, found 205.1563. 
?E) ? 1 ? ???????????????????? ? ?,4 ? ???????????? ? 1 ? ?n ?????? Prepared according to 
method ? as a colorless oil (76.8 mg, 79%) with a methylation/proto-
destannation ratio of 90:10, as determined by 1H NMR and GCMS. 
1H NMR (400 MHz, CDCl3): δ 5.73 (br s, 1H), 5.59 (app. dt, J = 3.9, 2.0 Hz, 
1H), 3.58 (d, J = 8.1 Hz, 1H), 2.09 (dq, J = 6.6, 2.7 Hz, 4H), 1.82-1.72 (m, 1H), 1.74 (d, J = 
1.2 Hz, 3H), 1.67-1.53 (m, 5H), 0.98 (d, J = 6.6 Hz, 3H), 0.80 (d, J = 6.8 Hz, 3H); 13C NMR 
(101 MHz, CDCl3): δ 136.1 (CR4), 134.8 (CR4), 129.9 (CH), 127.1 (CH), 84.7 (CH), 31.3 
(CH), 29.3 (CH2), 25.6 (CH2), 22.9 (CH2), 22.2 (CH2), 19.5 (CH3), 18.6 (CH3), 13.2 (CH3); 
FTIR (thin film): ν 3387, 2925, 2869, 2833, 1447, 1379, 1365, 1295, 1242, 1169, 1132, 
1009, 923, 885, 801 cm–1; HRMS (ESI): exact mass calculated for C13H22ONa [(M+Na)+] 
217.1563, found 217.1563. 
?E????????????????????????????????????????? ????????????? Prepared according to 
method ? as a colorless oil (87.2 mg, 86%) with a 
methylation/protodestannation ratio of 99:1, as determined by 1H 
NMR and GCMS. 1H NMR (400 MHz, CDCl3): δ 7.59 (d, J = 8.4 Hz, 2H), 
7.32 (d, J = 8.1 Hz, 2H), 6.69 (d, J = 1.6 Hz, 1H), 1.87 (d, J = 1.3 Hz, 3H), 1.70 (s, 1H), 1.43 
(s, 6H); 13C NMR (101 MHz, CDCl3): δ 148.0 (CR4), 143.4 (CR4), 131.8 (2 × CH), 129.6 
(2 × CH), 121.1 (CH), 119.1 (CR4), 109.5 (CR4), 73.9 (CR4), 28.9 (2 × CH3), 14.7 (CH3); 
FTIR (thin film): ν 3430, 2975, 2931, 2871, 2226, 1642, 1603, 1502, 1462, 1446, 1408, 
1363, 1240, 1211, 1170, 1115, 959, 941, 879, 821 cm–1; HRMS (ESI): exact mass 
calculated for C13H15NONa [(M+Na)+] 224.1046, found 224.1044. 
?E?????????????????????????????????????????????? Prepared according to method ? 
as a colorless oil (98.8 mg, 81%) with a methylation/protode-
stannation ratio of 99:1, as determined by 1H NMR and GCMS. 
1H NMR (400 MHz, CDCl3): δ 7.24-7.16 (m, 2H), 7.14-7.09 (m, 
3H), 5.29 (app. tp, J = 7.3, 1.2 Hz,1H), 3.96 (t, J = 6.6 Hz, 1H), 2.62 (ddd, J = 13.8, 9.4, 6.4 
Hz, 1H), 2.52 (ddd, J = 13.8, 9.1, 6.9 Hz, 1H), 2.27 (t, J = 7.1 Hz, 2H), 2.15 (app. q, J = 7.3 
Hz, 2H), 1.79 (dddd, J = 9.2, 6.8, 6.1, 4.9 Hz, 2H), 1.67 (p, J = 7.2 Hz, 2H), 1.58 (app. t, J = 
1.1 Hz, 3H), 1.48 (br s, 1H); 13C NMR (101 MHz, CDCl3): δ 141.8 (CR4), 139.6 (CR4), 128.4 
??
?
(4 × CH), 125.8 (CH), 123.7 (CH), 119.7 (CR4), 76.9 (CH), 36.6 (CH2), 32.1 (CH2), 26.4 
(CH2), 25.1 (CH2), 16.6 (CH2), 11.7 (CH3); FTIR (thin film): ν 3428, 3026, 2929, 2860, 
2247, 1603, 1495, 1454, 1304, 1156, 1055, 1030, 1008, 918, 870, 749, 700 cm–1; HRMS 
(ESI): exact mass calculated for C16H21NONa [(M+Na)+] 266.1515, found 266.1514. 
?E?????????????????????????????????????? Prepared according to method ? as a 
colorless oil (86.4 mg, 82%) with a methylation/protodestannation 
ratio of >99:1, as determined by 1H NMR and GCMS. 1H NMR 
(400 MHz, CDCl3): δ 5.32 (ddq, J = 8.3, 5.8, 1.2 Hz, 1H), 3.61 (d, J = 
8.3 Hz, 1H), 2.05-1.96 (m, 3H), 1.80-1.60 (m, 3H), 1.57 (app. q, J = 1.0 Hz, 3H), 1.48-1.07 
(m, 10H), 0.99-0.78 (m, 5H); 13C NMR (101 MHz, CDCl3): δ 135.9 (CR4), 128.3 (CH), 83.3 
(CH), 40.6 (CH), 31.7 (CH2), 29.6 (CH2), 29.3 (CH2), 27.2 (CH2), 26.5 (CH2), 26.2 (CH2), 
26.0 (CH2), 22.4 (CH2), 14.0 (CH3), 11.1 (CH3); FTIR (thin film): ν 3360, 2955, 2920, 2851, 
1449, 1378, 1306, 1290, 1260, 1206, 1081, 1054, 1008, 891, 851 cm–1; HRMS (ESI): exact 
mass calculated for C14H26ONa [(M+Na)+] 233.1876, found 233.1873. 
?E) ? 4 ? ????????xy ? 2,3 ? ??????????????????????????????????? Prepared according 
to method ? as a colorless oil (87.1 mg, 85%) with a 
methylation/protodestannation ratio of 98:2, as determined by 1H 
NMR and GCMS.  
The same compound was prepared according to method ? as a colorless oil (82.9 mg, 
81%) with a methylation/protodestannation ratio of 98:2, as determined by 1H NMR and 
GCMS. 1H NMR (400 MHz, CDCl3): δ 9.95 (s, 1H), 7.80 (d, J = 8.3 Hz, 2H), 7.37 (d, 
J = 8.2 Hz, 2H), 6.71 (s, 1H), 1.97 (s, 1H), 1.89 (d, J = 1.4 Hz, 3H), 1.43 (s, 6H); 13C NMR 
(101 MHz, CDCl3): δ 191.9 (CH), 147.7 (CR4), 145.1 (CR4), 134.1 (CR4), 129.5 (4 × CH), 
121.5 (CH), 73.8 (CR4), 28.9 (2 × CH3), 14.8 (CH3); FTIR (thin film): ν 3434, 2974, 2930, 
2831, 2735, 1687, 1646, 1599, 1563, 1462, 1445, 1416, 1362, 1306, 1212. 1166, 1112, 
978, 959, 941, 879, 825, 788, 745 cm–1; HRMS (ESI): exact mass calculated for 
C13H16O2Na [(M+Na)+] 227.1042, found 227.1041. 
????l ??E??E?????????????????????????????????????????? Prepared according to 
method ? as a colorless oil (99.5 mg, 83%) with a 
methylation/protodestannation ratio of 97:3, as determined by 
??
?
1H NMR and GCMS.  
The same compound was prepared according to method ? as a colorless oil (106 mg, 
88%) with a methylation/protodestannation ratio of 95:5, as determined by 1H NMR and 
GCMS. 1H NMR (400 MHz, CDCl3): δ 6.08 (p, J = 1.4 Hz, 1H), 5.53 (t, J = 7.2 Hz, 1H), 4.44 (s, 
1H), 4.15 (qd, J = 7.1, 1.3 Hz, 2H), 2.04 (q, J = 7.3 Hz, 2H), 1.99 (d, J = 1.4 Hz, 3H), 1.87 (d, J 
= 2.6 Hz, 1H), 1.49 (d, J = 1.2 Hz, 3H), 1.41-1.22 (m, 7H), 0.89 (t, J = 7.1 Hz, 3H); 13C NMR 
(101 MHz, CDCl3): δ 166.9 (CR4), 157.7 (CR4), 133.7 (CR4), 130.3 (CH), 115.0 (CH), 81.6 
(CH), 59.7 (CH2), 31.5 (CH2), 27.4 (CH2), 22.3 (CH2), 15.5 (CH3), 14.3 (CH3), 13.9 (CH3), 
11.1 (CH3); FTIR (thin film): ν 3475, 2957, 2928, 2859, 1716, 1698, 1446, 1367, 1342, 
1280, 1211, 1144, 1042, 995, 892 cm–1; HRMS (ESI): exact mass calculated for 
C14H24O3Na [(M+Na)+] 263.1618, found 263.1615. 
?E??????????????????????????????????????? Prepared according to method ? as a 
colorless oil (94.5 mg, 72%) with a methylation/protode-
stannation ratio of 97:3, as determined by 1H NMR and GCMS. 
1H NMR (400 MHz, CDCl3): δ 5.68 (q, J = 1.2 Hz, 1H), 5.53-5.47 (m, 
2H), 4.35 (dd, J = 8.1, 5.0 Hz, 1H), 2.68-2.56 (m, 2H), 2.01 (q, J = 7.2 Hz, 2H), 1.68 (br s, 
1H), 1.63 (s, 3H), 1.40-1.22 (m, 6H), 0.88 (t, J = 6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ 
135.2 (CR4), 130.7 (CR4), 127.8 (CH), 119.3 (CH2), 74.9 (CH), 47.4 (CH2), 31.5 (CH2), 29.1 
(CH2), 27.5 (CH2), 22.6 (CH2), 14.1 (CH3), 11.6 (CH3); FTIR (thin film): ν 3379, 2956, 
2924, 2856, 1632, 1458, 1378, 1300, 1200, 1115, 1017, 885, 570 cm–1; HRMS (ESI): exact 
mass calculated for C12H21OBrNa [(M+Na)+] 283.0668, found 283.0665. 
?E????????????????????????????????? Prepared according to method ? as a colorless oil 
(49.8 mg, 67%) with a methylation/protodestannation ratio of 98:2, 
as determined by 1H NMR and GCMS. 1H NMR (400 MHz, CDCl3): δ 
5.37 (tdd, J = 7.3, 2.6, 1.3 Hz, 1H), 3.99 (s, 2H), 3.52 (t, J = 6.6 Hz, 2H), 2.19 (q, J = 7.1 Hz, 
2H), 1.83 (p, J = 6.7 Hz, 2H), 1.68 (br s, 1H), 1.67 (s, 3H); 13C NMR (101 MHz, CDCl3): δ 
136.3 (CR4), 123.9 (CH), 68.7 (CH2), 44.5 (CH2), 32.2 (CH2), 24.7 (CH2), 13.7 (CH3); FTIR 
(thin film): ν 3322, 2935, 2917, 2862, 1443, 1385, 1346, 1308, 1287, 1230, 1065, 1038, 
1007, 861, 844, 746, 723 cm–1; HRMS (ESI): exact mass calculated for C7H13O(35Cl)Na 





according to method ? as a colorless oil (144 mg, 76%) with a 
methylation/protodestannation ratio of 96:4, as determined 
by 1H NMR and GCMS. 1H NMR (400 MHz, CDCl3): δ 7.83 (dd, J 
= 5.4, 3.1 Hz, 2H), 7.70 (dd, J = 5.5, 3.1 Hz, 2H), 7.29-7.24 (m, 2H), 7.20-7.14 (m, 3H), 5.37 
(t, J = 7.1 Hz, 1H), 4.01 (t, J = 6.7 Hz, 1H), 3.68 (t, J = 7.3 Hz, 2H), 2.67 (ddd, J = 13.8, 9.8, 
6.2 Hz, 1H), 2.57 (ddd, J = 13.9, 9.5, 6.5 Hz, 1H), 2.09 (br q, J = 7.4 Hz, 2H), 1.94-1.75 (m, 
2H), 1.74-1.63 (m, 3H), 1.62 (s, 3H), 1.43 (p, J = 7.4 Hz, 2H); 13C NMR (101 MHz, CDCl3): δ 
168.4 (2 × CR4), 142.1 (CR4), 137.6 (CR4), 133.8 (2 × CR4), 132.1 (2 × CH), 128.4 (2 × CH), 
128.3 (2 × CH), 126.2 (CH), 125.7 (CH), 123.1 (2 × CH), 77.3 (CH), 37.8 (CH2), 36.4 (CH2), 
32.1 (CH2), 28.0 (CH2), 26.9 (CH2), 26.5 (CH2), 11.3 (CH3); FTIR (thin film): ν 3467, 3061, 
3026, 2937, 2859, 1770, 1705, 1604, 1495, 1467, 1453, 1437, 1396, 1369, 1337,.1188, 
1037, 920, 892, 867, 749, 719, 700 cm–1; HRMS (ESI): exact mass calculated for 
C24H27NO3Na [(M+Na)+] 400.1883, found 400.1880. 
?E????????????????????????????????? Prepared from (Z)-1-phenyl-5-
(tributylstannyl)dec-5-en-3-ol (86:15 mixture of pro-
ximal/distal vinyl stannane, 261 mg, 501 µmol) according to 
method ? as a faintly yellowish oil (85:15 mixture of proximal/distal product, 103 mg, 
84%) with a methylation/protodestannation ratio of 92:8, as determined by 1H NMR and 
GCMS. 1H NMR (87:13 mixture of proximal/distal product, only resonances of the major 
isomer are reported, 400 MHz, CDCl3): δ 7.33-7.26 (m, 2H), 7.24-7.15 (m, 3H), 5.27 (tq, J 
= 7.2, 1.3 Hz, 1H), 3.71 (dtd, J = 9.6, 6.1, 3.7 Hz, 1H), 2.90-2.77 (m, 1H), 2.71 (dt, J = 13.7, 
8.1 Hz, 1H), 2.23 (dd, J = 13.2, 3.3 Hz, 1H), 2.12-1.96 (m, 3H), 1.85-1.66 (m, 3H), 1.62 (d, J 
= 1.2 Hz, 3H), 1.40-1.24 (m, 4H), 0.95-0.85 (m, 3H); 13C NMR (87:13 mixture of 
proximal/distal product, only resonances of the major isomer are reported,101 MHz, 
CDCl3): δ 142.3 (CR4), 131.6 (CR4), 129.2 (CH), 128.4 (2 × CH), 128.3 (2 × CH), 125.7 (CH), 
67.7 (CH), 48.1 (CH2), 38.7 (CH2), 32.2 (CH2), 31.9 (CH2), 27.7 (CH2), 22.4 (CH2), 16.0 
(CH3), 14.0 (CH3); FTIR (thin film): ν 3375, 3062, 3026, 2954, 2925, 2857, 1603, 1495, 
1454, 1380, 1266, 1181, 1079, 1050, 1029, 929, 840, 745, 698 cm–1; HRMS (ESI): exact 
mass calculated for C17H30NO [(M+NH4)+] 264.2322, found 264.2318. 
??
?
??SR??SR?E???????????????????????????? Prepared from (2SR,3RS,Z)-3-methyl-4-
(tributylstannyl)non-4-en-2-ol (94:6 mixture of proximal/distal 
vinyl stannane, 224 mg, 503 µmol) according to method ? as a 
faintly yellowish oil (94:6 mixture of proximal/distal product, 
72.2 mg, 84%) with a methylation/protodestannation ratio of 94:6, as determined by 1H 
NMR and GCMS. 1H NMR (94:6 mixture of proximal/distal product, only resonances of 
the major isomer are reported, 400 MHz, CDCl3): δ 5.21 (tp, J = 7.1, 1.3 Hz, 1H), 3.72 (p, J 
= 6.3 Hz, 1H), 2.08-1.96 (m, 3H), 1.57 (s, 3H), 1.47 (br s, 1H), 1.37-1.26 (m, 4H), 1.13 (d, J 
= 6.3 Hz, 3H), 1.04 (d, J = 7.0 Hz, 3H), 0.94-0.83 (m, 3H); 13C NMR (94:6 mixture of 
proximal/distal product, only resonances of the major isomer are reported, 101 MHz, 
CDCl3): 137.0 (CR4), 126.3 (CH), 69.2 (CH), 49.7 (CH), 31.9 (CH2), 27.4 (CH2), 22.4 (CH2), 
21.2 (CH3), 14.4 (CH3), 13.99 (CH3), 13.95 (CH3); FTIR (thin film): ν 3362, 2959, 2926, 
2873, 2859, 1455, 1372, 1298, 1249, 1157, 1081, 1026, 972, 952, 908, 850, 727 cm–1; 
HRMS (ESI): exact mass calculated for C11H22ONa [(M+Na)+] 193.1563, found 193.1563. 
??RS??SR??????E????????????????????????????????? Prepared from (1RS,2RS)-2-((Z)-1-
(tributylstannyl)hex-1-en-1-yl)cyclohexan-1-ol (85:15 mixture of 
proximal/ distal vinyl stannane, 236 mg, 501 µmol) according to 
method ? as a faintly yellowish oil (87:13 mixture of proximal/distal 
product, 59.7 mg, 61%) with a methylation/protodestannation ratio of 94:6, as 
determined by 1H NMR and GCMS. 1H NMR (87:13 mixture of proximal/distal product, 
only resonances of the major isomer are reported, 400 MHz, CDCl3): δ 5.32 (ddd, J = 8.6, 
6.3, 1.5 Hz, 1H), 3.40 (td, J = 10.0, 4.2 Hz, 1H), 2.12-1.97 (m, 3H), 1.88-1.59 (m, 5H), 1.56 
(d, J = 1.3 Hz, 3H), 1.40-1.12 (m, 8H), 0.89 (t, J = 7.1 Hz, 3H); 13C NMR (87:13 mixture of 
proximal/distal product, only resonances of the major isomer are reported, 101 MHz, 
CDCl3): 135.3 (CR4), 128.6 (CH), 70.2, 56.3, 34.0, 31.9, 30.0, 27.4, 25.7, 24.9, 22.4, 14.0, 
12.5; δ 142.3 (CR4), 131.6 (CR4), 129.2 (CH), 128.4 (2 × CH), 128.3 (2 × CH), 125.7 (CH), 
67.7 (CH), 48.1 (CH2), 38.7 (CH2), 32.2 (CH2), 31.9 (CH2), 27.7 (CH2), 22.4 (CH2), 16.0 
(CH3), 14.0 (CH3); FTIR (thin film): ν 3441, 2954, 2926, 2856, 1449, 1379, 1352, 1270, 
1132, 1106, 1063, 1042, 1008, 945, 843 cm–1; HRMS (ESI): exact mass calculated for 
C13H25O [(M+H)+] 197.1900, found 197.1899. 
??
?
??RS??SR??????E?????????????????????????????????? Prepared from (1RS,2RS)-2-((Z)-
1-(tributylstannyl)hex-1-en-1-yl)cyclopentan-1-ol (85:15 mixture of 
proximal/ distal vinyl stannane, 229 mg, 501 µmol) according to 
method ? as a faintly yellowish oil (86:14 mixture of proximal/distal product, 60.4 mg, 
66%) with a methylation/protodestannation ratio of 98:2, as determined by 1H NMR and 
GCMS. 1H NMR (86:14 mixture of proximal/distal product, only resonances of the major 
isomer are reported, 400 MHz, CDCl3): δ 5.25 (tp, J = 7.1, 1.3 Hz, 1H), 3.96 (q, J = 7.4 Hz, 
1H), 2.24 (dt, J = 10.3, 7.8 Hz, 1H), 1.99 (ddt, J = 12.8, 10.3, 7.3 Hz, 3H), 1.83-1.45 (m, 6H), 
1.58 (s, 3H), 1.39-1.24 (m,4H), 0.89 (t, J = 7.1 Hz, 3H); 13C NMR (86:14 mixture of 
proximal/distal product, only resonances of the major isomer are reported,101 MHz, 
CDCl3): δ 134.7 (CR4), 126.2 (CH), 75.7 (CH), 57.8 (CH), 33.6 (CH2), 32.0 (CH2), 28.2 (CH2), 
27.6 (CH2), 22.4 (CH2), 21.3 (CH2), 14.0 (CH3), 13.3 (CH3); FTIR (thin film): ν 3336, 2955, 
2926, 2871, 1453, 1378, 1341, 1299, 1247, 1151, 1086, 1050, 975, 937, 838, 727 cm–1; 
HRMS (ESI): exact mass calculated for C12H23O [(M+H)+] 183.1743, found 183.1743. 
?E?????????????????????????????????l ???????????? Prepared according to method ? 
as a colorless oil (164 mg, 75%) with a 
methylation/protodestannation ratio of >99:1, as 
determined by 1H NMR and GCMS. 1H NMR (400 MHz, CDCl3): δ 5.08 (t, J = 6.7 Hz, 1H), 
4.04 (t, J = 6.7 Hz, 4H), 2.27 (t, J = 7.5 Hz, 4H), 1.95 (app. q, J = 7.7 Hz, 4H), 1.60 (tt, J = 7.6, 
4.1 Hz, 8H), 1.56 (s, 3H), 1.42-1.22 (m, 20H), 0.88 (t, J = 6.8 Hz, 6H); 13C NMR (101 MHz, 
CDCl3): δ 173.9 (2 × CR4), 135.0 (CR4), 124.4 (CH), 64.3 (2 × CH2), 39.5 (CH2), 34.3 
(2 × CH2), 31.3 (2 × CH2), 29.7 (CH2), 28.87 (CH2), 28.83 (CH2), 28.6 (2 × CH2), 27.78 
(CH2), 27.74 (CH2), 25.83 (CH2), 25.80 (CH2), 24.7 (2 × CH2), 22.3 (2 × CH2), 15.8 (CH3), 
13.9 (2 × CH3); FTIR (thin film): ν 2954, 2928, 2857, 1735, 1463, 1381, 1355, 1244, 1169, 
1099, 1067, 944, 889, 851, 729 cm–1; HRMS (ESI): exact mass calculated for C27H50O4Na 











????????????? ?????? LiOtBu (0.9 M in 2-Me-THF, 0.33 mL, 300 µmol) was added to a 
suspension of CuI (58.0 mg, 305 µmol) in DMF (0.50 mL) at 0 °C, the cooling bath was 
removed and the resulting dark brown solution was stirred at ambient temperature for 
30 min. A solution of (Z)-1-phenyl-4-(triethoxysilyl)non-4-en-3-ol (??) (38.0 mg, 
99.8 µmol) in DMF (0.6 mL) was added, immediately followed by MeI (19.0 µL, 
305 µmol). The resulting mixture was stirred until TLC control showed complete 
conversion of the substrate before the reaction was quenched with Et3N (0.1 mL). The 
mixture was diluted with tert-butyl methyl ether (30 mL) and poured into a mixture of 
25% aqueous NH4OH/sat. aqueous NH4Cl solution (1:9, 10 mL). The aqueous phase was 
extracted with tert-butyl methyl ether (2 × 30 mL), the combined extracts were washed 
with brine (3 x) and then dried over Na2SO4, filtered and concentrated under reduced 
pressure, and the residue was purified by flash chromatography (EtOAc/hexane 2:98 to 
10:90; step gradient) to give the title compound (27.2 mg, 69%) as colorless oil. 1H NMR 
(400 MHz, CDCl3): δ 7.30-7.24 (m, 2H), 7.22-7.14 (m, 3H), 5.39 (t, J = 7.1 Hz, 1H), 4.27 (t, J 
= 6.7 Hz, 1H), 3.82 (q, J = 7.0 Hz, 6H), 2.66-2.48 (m, 2H), 2.03 (q, J = 7.0 Hz, 2H), 1.99-1.89 
(m, 1H), 1.82 (dddd, J = 13.3, 10.2, 6.5, 5.7 Hz, 1H), 1.61 (s, 3H), 1.39-1.28 (m, 4H), 1.21 (t, 
J = 7.0 Hz, 9H), 0.94-0.87 (m, 3H); 13C NMR (101 MHz, CDCl3): δ 142.4 (CR4), 135.7 (CR4), 
128.4 (2 × CH), 128.2 (2 × CH), 127.1 (CH), 125.6 (CH), 78.7 (CH), 59.1 (3 × CH2), 37.3 
(CH2), 32.0 (CH2), 31.7 (CH2), 27.2 (CH2), 22.4 (CH2), 18.1 (3 × CH3), 14.0 (CH3), 10.9 
(CH3); FTIR (thin film): ν 3027, 2973, 2927, 1604, 1496, 1554, 1390, 1296, 1168, 1103, 
1079, 965, 791 cm−1; HRMS (ESI): exact mass calculated for C22H38O4SiNa [(M+Na)+] 
417.2432, found 417.2424. 
??
?
?E?????????????????????????????????????????????????????????????? The reaction 
was performed analogously; the crude product was analytically 
pure (>98% by NMR, 54 mg, 91%). 1H NMR (400 MHz, CDCl3) δ 
7.30-7.24 (m, 2H), 7.21-7.14 (m, 3H), 5.37 (t, J = 7.2 Hz, 1H), 
4.21 (t, J = 6.7 Hz, 1H), 3.78 (qd, J = 7.1, 2.8 Hz, 4H), 2.58 (m, 2H), 2.02 (m, 2H), 1.86 (m, 
2H), 1.60 (s, 3H), 1.39-1.28 (m, 4H), 1.20 (t, J = 7.0 Hz, 6H), 0.90 (m, 3H), 0.09 (s, 3H); 13C 
(101 MHz, CDCl3) δ 142.4, 136.0, 128.4, 128.3, 127.0, 125.6, 78.1, 58.22, 58.19, 37.5, 32.1, 
31.7, 27.2, 22.4, 18.24, 18.22, 14.0, 10.92, -6.44; FTIR (thin film): ṽ 3086, 3063, 3027, 
2958, 2926, 2874, 1742, 1604, 1496, 1454, 1389, 1334, 1295, 1262, 1167, 1102, 1075, 
984, 957, 888, 824, 790, 767, 748, 698 cm-1; HRMS (ESI): exact mass calculated for 
C21H36O3SiNa [(M+Na)+] 387.2326, found 387.2327. 
?E??????????????????????????????????????????????????????????????????? Prepared 
according to the general procedure as a colorless oil (26 mg, 76 
%). 1H NMR (400 MHz, CDCl3) δ 7.31-7.25 (m, 2H), 7.21-7.15 (m, 
3H), 5.32 (t, J = 7.1 Hz, 1H), 4.23 (t, J = 6.5 Hz, 1H), 3.79 (m, 4H), 
2.59 (m, 2H), 2.35 (t, J = 7.2 Hz, 2H), 2.21 (m, 2H), 1.98-1.76 (m, 2H), 1.74 (t, J = 7.2 Hz, 
2H), 1.64 (s, 3H), 1.21 (td, J = 7.0, 0.8 Hz, 6H), 0.10 (s, 3H); 13C (101 MHz, CDCl3) δ 142.1, 
139.0, 128.34, 128.29, 125.7, 123.4, 119.6, 77.5, 58.25, 58.22, 37.4, 32.0, 26.2, 25.2, 
18.23, 16.5, 11.4, -6.5; FTIR (thin film): ṽ 3063, 3027, 2973, 2927, 2885, 2247, 1603, 
1496, 1454, 1390, 1366, 1333, 1294, 1263, 1166, 1100, 1071, 985, 956, 889, 822, 788, 
767, 750, 699 cm-1; HRMS (ESI): exact mass calculated for C21H33NO3SiNa [(M+Na)+] 
398.2122, found 398.2124. 
????l ????????????????????????????????????????????????????????????????????. 
Prepared according to the general procedure as a colorless oil (28 
mg, 79 %). 1H NMR (400 MHz, CDCl3) δ 6.10 (qui, J = 1.4 Hz, 1H), 
5.51 (t, J = 7.1 Hz, 1H), 4.59 (s, 1H), 4.16 (q, J = 7.2 Hz, 2H), 3.77 (m, 4H), 2.03 (q, J = 7.1 
Hz, 2H), 1.98 (s, 3H), 1.45 (s, 3H), 1.33 (m, 4H), 1.29 (t, J = 7.1 Hz, 3H), 1.20 (td, J = 7.1, 1.9 
Hz, 6H), 0.89 (m, 3H), 0.10 (s, 3H); 13C (101 MHz, CDCl3) δ 167.1, 157.9, 133.5, 129.6, 
114.9, 81.7, 59.6, 58.37, 58.34, 31.5, 27.4, 22.3, 18.18, 15.3, 14.3, 13.9, 10.7, -6.5; FTIR 
(thin film): ṽ 2973, 2927, 2875, 1717, 1654, 1444, 1388, 1367, 1315, 1263, 1211, 1144, 
??
?
1073, 1004, 957, 887, 826, 792, 763, 734 cm-1; HRMS (ESI): exact mass calculated for 
C19H36O5SiNa [(M+Na)+] 395.2224, found 395.2224. 
?E???????????????????????????????????????????????????????????????????????????. 
Prepared according to the general procedure as a colorless oil (26 
mg, 80 %). 1H NMR (400 MHz, CDCl3) δ 5.77 (s (br), 1H), 5.58 (m, 
1H), 4.39 (q, J = 6.4 Hz, 1H), 3.79 (qd, J = 7.0, 1.5 Hz, 4H), 2.09 (m, 
4H), 1.76 (s, 3H), 1.60 (m, 4H), 1.27 (d, J = 6.3 Hz, 3H), 1.21 (t, J = 7.0 Hz, 6H), 0.11 (s, 
3H); 13C (101 MHz, CDCl3) δ 137.5, 135.0, 127.1, 126.7, 74.4, 58.23, 58.21, 29.2, 25.6, 
23.0, 22.8, 22.2, 18.24, 18.23, 13.1, -6.5; FTIR (thin film): ṽ 2973, 2927, 2835, 1650, 1439, 
1390, 1369, 1334, 1312, 1294, 1262, 1199, 1167, 1102, 1074, 991, 956, 880, 865, 825, 
779 cm-1; HRMS (ESI): exact mass calculated for C16H30O3SiNa [(M+Na)+] 321.1856, 
found 321.1854. 
?E?????????????????????????????????????????????????????????????????. Prepared 
according to the general procedure; the crude product was pure 
enough for further use (55 mg, 99 %). 1H NMR (400 MHz, CDCl3) δ 
7.30-7.24 (m, 2H), 7.21-7.15 (m, 3H), 5.50 (tq, J = 7.0, 1.3 Hz, 1H), 
3.77 (q, J = 7.0 Hz, 4H), 2.66 (m, 2H), 2.32 (m, 2H), 1.60 (s, 3H), 1.38 (s, 6H), 1.21 (t, J = 
7.0 Hz, 6H), 0.10 (s, 3H); 13C (101 MHz, CDCl3) δ 142.3, 141.6, 128.5, 128.2, 125.7, 121.1, 
76.6, 58.0, 35.8, 29.9, 29.2, 18.2, 12.5, -4.7; FTIR (thin film): ṽ 3086, 3063, 3027, 2974, 
2926, 2882, 1604, 1496, 1454, 1388, 1376, 1364, 1294, 1262, 1160, 1104, 1076, 1048, 
995, 815, 778, 747, 698 cm-1; HRMS (ESI): exact mass calculated for C19H32O3SiNa 
[(M+Na)+] 359.2013, found 359.2015. 
?E??????????????????????????????????????????????????????????????????????????. 
Prepared according to the general procedure as a colorless oil (20 
mg, 48 %). 1H NMR (400 MHz, CDCl3) δ 9.99 (s, 1H), 7.84 (m, 2H), 
7.40 (m, 2H), 6.67 (s, 1H), 3.82 (q, J = 7.0 Hz, 4H), 1.90 (d, J = 1.3 
Hz, 3H), 1.52 (s, 6H), 1.23 (t, J = 6.9 Hz, 6H), 0.17 (s, 3H); 13C (101 MHz, CDCl3) δ 191.9, 
147.5, 145.4, 134.2, 129.60, 129.54, 121.6, 77.0, 58.2, 29.2, 18.3, 14.6, -4.7; FTIR (thin 
film): ṽ 2975, 2927, 2881, 2825, 2734, 1720, 1698, 1649, 1602, 1566, 1507, 1482, 1443, 
1415, 1388, 1364, 1304, 1263, 1246, 1212, 1165, 1102, 1075, 1045, 1003, 981, 951, 876, 
??
?
817, 778, 732, 708, 650 cm-1; HRMS (ESI): exact mass calculated for C18H29O4Si [(M+H)+] 





(0.9 M solution in 2-Me-THF, 0.33 mL, 300 µmol) was added to a suspension of CuI 
(58.0 mg, 305 µmol) in DMF (0.50 mL) at 0 °C, the cooling bath was removed and the 
resulting dark brown solution was stirred at ambient temperature for 30 min. A solution 
of (Z)-4-(diethoxy(methyl)silyl)-1-phenylnon-4-en-3-ol (35.0 mg, 99.8 µmol) in DMF 
(0.6 mL) was added, followed  within maximum 30 seconds  by 3-chloro-2-
methylpropene (30 µL, 304 µmol). The resulting mixture was stirred for 4 hours before 
the reaction was quenched with Et3N (0.1 mL). The mixture was diluted with tert-butyl 
methyl ether (30 mL), poured on a mixture of 25% aqueous NH4OH/sat. aqueous NH4Cl 
solution (1:9, 10 mL), the phases were separated and the aqueous phase extracted with 
tert-butyl methyl ether (2 × 30 mL). The combined organic layers were dried over 
Na2SO4, filtered and concentrated under reduced pressure. Purification of the residue by 
flash chromatography (EtOAc/hexane 1:99 to 5:95; step gradient) afforded the title 
compound (34.2 mg, 85%) as colorless oil. 1H NMR (400 MHz, CDCl3): δ 7.29-7.23 (m, 
2H), 7.20-7.14 (m, 3H), 5.62 (t, J = 7.1 Hz, 1H), 4.74 (s, 1H), 4.69 (s, 1H), 4.28 (t, J = 6.0 Hz, 
1H), 3.81 (ttd, J = 7.0, 4.5, 2.3 Hz, 4H), 2.82 (d, J = 15.9 Hz, 1H), 2.71 (d, J = 15.9 Hz, 1H), 
2.75-2.54 (m, 2H), 2.02 (td, J = 7.0, 3.4 Hz, 2H), 1.88-1.80 (m, 2H), 1.72 (s, 3H), 1.40-1.29 
(m, 4H), 1.22 (td, J = 7.0, 1.6 Hz, 6H), 0.90 (t, J = 7.1 Hz, 3H), 0.11 (s, 3H); 13C NMR 
(101 MHz, CDCl3): δ 143.3 (CR4), 142.6 (CR4), 137.2 (CR4), 128.5 (CH), 128.4 (2 × CH), 
128.2 (2 × CH), 125.6 (CH), 110.9 (CH2), 75.9 (CH), 58.2 (2 × CH2), 38.2 (CH2), 35.5 (CH2), 
32.0 (CH2), 31.8 (CH2), 27.6 (CH2), 22.9 (CH3), 22.5 (CH2), 18.3 (2 × CH3), 14.0 (CH3), −6.4 
(CH3); FTIR (thin film): ν 3027, 2969, 2925, 1646, 1604, 1496, 14454, 1389, 1262, 1167, 
1077987, 957, 890, 823, 792, 767, 748 cm−1; HRMS (ESI): exact mass calculated for 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chemicals and Solvents: All chemicals and solvents were purchased from ABCR, ACROS, 
ALFA–AESAR, APOLLO SCIENTIFIC, FLUKA, FLUOROCHEM, MERCK, SIGMA-ALDRICH, TCI, or STREM 
CHEMICALS and used as received, unless mentioned otherwise.1 Et2O and THF were 
distilled from Mg/anthracene, CH2Cl2 and EtOAc from CaH2, toluene from Na/K, and 
MeOH from Mg turnings under an inert atmosphere of nitrogen or argon. DMF, DMSO, 
MeCN, Et3N and pyridine were dried by passage through molecular sieve colums (H2O 
content < 30 ppm, KARL–FISCHER titration) using a VACUUM ATMOSPHERES COMPANY Solvent 
Purifier system.2 Dry acetone was obtained by drying over B2O3, followed by filtration 
and distillation.3 2,6-Lutidine was distilled from CaH2 under an inert atmosphere of 
argon. [(Cp*)RuCl2]n was prepared according to a literature procedure.4 Copper(I) 
thiophene-2-carboxylate (CuTC) could either be prepared according to a literature 
procedure5 or purchased from SIGMA-ALDRICH without noticeable differences in 
reactivity. (Bu4N)OP(O)Ph2 was prepared by a slightly adapted procedure (vide infra).6 
All hygroscopic or air-sensitive chemicals were stored in SCHLENK-flasks under an 
atmosphere of argon at the appropriate temperature, as indicated by the supplier. 
General Procedures: All non-aqueous reactions were performed under an inert 
atmosphere of dry argon at ca. 0.4 bar overpressure using flame dried glassware, unless 
otherwise noted. Reactions were stirred using magnetic stir-bars and monitored by thin 
layer chromatography (TLC). Analytical thin layer chromatography was performed using 
MACHEREY–NAGEL POLYGRAM SIL G/UV pre-coated polyester plates and visualized by 
ultraviolet light (UV). Additionally, TLC plates were stained with either aqueous 
potassium permanganate [1.5 g KMnO4, 200 mL H2O, 10 g K2CO3, 2.5 mL 1M NaOH aq.], 
cerium ammonium molybdate [0.5 g Ce(NH4)2(NO3)6, 12 g (NH4)6Mo7O24·4H2O, 235 mL 
H2O, 15 mL conc. H2SO4] or ethanolic p-anisaldehyde [3.7 mL p-anisaldehyde, 135 mL 
EtOH, 5 mL conc. H2SO4, 1.5 mL AcOH]. Concentration under reduced pressure (= in 
vacuo) was performed using commercial rotator evaporators. Chromatographic 
                                              
1 For general information on purification of chemicals and reagents, see: W. L. F. Armarego, C. L. L. Chai in 
“Purification of Laboratory Chemicals” 7th Edition, Elsevier, Amsterdam, 2013. 
2 A. B. Pangborn, M. A. Giardello, R. H. Grubbs, R. K. Rosen, F. J. Timmers, Organometallics 1996, 15, 1518-1520. 
3 D. R. Burfield, R. H. Smithers, J. Org. Chem. 1978, 43, 3966-3968. 
4 T. D. Tilley, R. H. Grubbs, J. E. Bercaw, Organometallics 1984, 3, 274-278. 
5 G. D. Allred, L. S. Liebeskind, J. Am. Chem. Soc. 1996, 118, 2748-2749. 
6 For the original procedure, see: J. Srogl, G. D. Allred, L. S. Liebeskind, J. Am. Chem. Soc. 1997, 119, 12376-12377.  
  
purification was performed as flash chromatography7 on MERCK 60 Å (40-63 µm) silica 
gel at ca. 0.4 bar overpressure. Purified compounds were dried under high vacuum 
(10−3 mbar).  
Analytical Methods: Nuclear Magnetic Resonance (NMR): NMR data were recorded on a 
BRUKER AV 400 (Progeny cryoprobe) or BRUKER AVIII 600 (cryoprobe) spectrometer in 
the solvents indicated. Chemical shifts (δ) are reported in ppm with the residual solvent 
signal as internal standard (CDCl3 at 7.26 and 77.00 ppm for 1H and 13C NMR 
spectroscopy, respectively; CD3OD at 3.31 and 49.00 ppm for 1H and 13C NMR 
spectroscopy, respectively), unless otherwise noted. 1H NMR data are reported as δ 
(ppm) (s = singlet, d = doublet, t = triplet, q = quartet, qui = quintet, m = multiplet or 
unresolved, br = broad signal, app. = appearing as; coupling constant(s) (J) in Hz; 
integration). 13C NMR spectra were recorded with broadband 1H decoupling while 
J-coupling(s) to other NMR-active heteronuclei (i.e. 19F and 31P) are reported as (d = 
doublet, t = triplet, q = quartet, qui = quintet; coupling constant(s) in Hz). If HSQC or 
DEPT data were available the carbon atoms are denoted with (CH3 = methyl, CH2 = 
methylene, CH = methine, CR4 = fully substituted carbon atom). 31P NMR and 119Sn NMR 
spectra were referenced to H3PO4 (85% in D2O) and SnMe4, respectively, as external 
standards.  
Only experimentally observed and resolved signals are tabulated or compiled; therefore it is 
possible that the number of signals in the 13C NMR spectra does not match the expected 
number of magnetically inequivalent C-atoms in a given molecule. 
Fourier Transform Infrared Spectrometry (FTIR): FTIR spectra were recorded on a 
PERKIN ELMER Spectrum One FT-IR (UATR) instrument as thin films. Absorptions (ν) are 
given in wavenumbers (cm–1). 
High Resolution Mass Spectrometry (HRMS): HRMS analyses were performed as ESI 
measurements on a BRUKER 7T APEX III Fourier Transform Ion Cyclotron MS or a FINNIGAN 
MAT 95 instrument. 
                                              
7 W. C. Still, M. Kahn, A. J. Mitra, J. Org. Chem. 1978, 43, 2923-2925. 
  
 
Substrates, Reagents and Reference Compounds 
 
Except for the compounds outlined below, all other substrates were prepared as previously 
described; their analytical and spectral data are contained in the Supporting Information of 





Tetra-n-butylammonium diphenylphosphinate. To a suspension of Ph2PO2H (5.50 g, 
25.2 mmol) in dry MeOH (27.5 mL) at ambient temperature was added Bu4NOH (1.0 M 
in MeOH, 25.2 mL, 25.2 mmol) and the resulting yellow solution was stirred at that 
temperature for another 15 min. The mixture was filtered through a short pad of Celite, 
eluting with dry MeOH (25 mL), and the combined filtrates were concentrated under 
reduced pressure (water bath at 60 °C). The resulting pale yellow oil was dried under 
high vacuum for 8 h to afford a solid yellow wax, which was re-dissolved in dry EtOAc 
and the solvent evaporated again to remove residual MeOH. Recrystallization of the 
residue from EtOAc/Et2O (ca. 1:4, 50 mL; slow cooling from reflux to –20 °C) afforded 
Ph2PO2NBu4 (10.6 g, 92%) as white crystalline needles. 1H NMR (400 MHz, CDCl3): 
δ 7.92-7.85 (m, 4H), 7.27-7.18 (m, 6H), 3.31 (app. t, J = 8.4 Hz, 8H), 1.57 (app. quintet, J = 
7.9 Hz, 8H), 1.35 (sextet, J = 7.4 Hz, 8H), 0.92 (app. t, J = 7.3 Hz, 12H); 13C NMR (101 MHz, 
CDCl3): δ 131.7 (d, J = 8.6 Hz), 128.3 (br s), 127.2 (d, J = 11.3 Hz), 58.9 (s), 24.2 (s), 19.7 




                                              
8  a) S. M. Rummelt, K. Radkowski, D.-A. Roşca, A. Fürstner, J. Am. Chem. Soc. 2015, 137, 5506-5519; b) D.-A. 
Rosca, K. Radkowski, L. M. Wolf, M. Wagh, R. Goddard, W. Thiel, A. Fürstner, J. Am. Chem. Soc. 2017, 139, 2443-
2455; c) a) H. Sommer, A. Fürstner, Chem. Eur. J. 2017, 23, 558-562; b) H. Sommer, A. Fürstner, Org. Lett. 2016, 




1-Phenylnon-4-yn-3-ol. nBuLi, (1.6 M in hexanes, 21.5 mL, 34.4 mmol) was added to a 
solution of 1-hexyne (4.80 mL, 41.8 mmol) in THF (90 mL) at 0 °C and the resulting 
mixture was stirred at that temperature for 30 min. 3-Phenylpropanal (3.60 mL, 
27.3 mmol) was added and the resulting mixture was allowed to reach ambient 
temperature over 2 hours. The reaction was quenched by the addition of NH4Cl solution 
(50 mL, sat. aqueous) and the aqueous phase was extracted with tert-butyl methyl ether 
(3 × 100 mL). The combined extracts were dried over Na2SO4, filtered and concentrated 
under reduced pressure. Purification of the residue by flash chromatography 
(EtOAc/hexane 15:85) afforded the title compound (5.62 g, 99%) as a colorless oil. 
1H NMR (400 MHz, CDCl3): δ 7.32-7.27 (m, 2H), 7.24-7.17 (m, 3H), 4.37 (tt, J = 6.5, 2.0 Hz, 
1H), 2.80 (t, J = 7.9 Hz, 2H), 2.24 (td, J = 7.0, 2.0 Hz, 2H), 2.07-1.93 (m, 2H), 1.84 (br s, 
1H), 1.55-1.39 (m, 4H), 0.94 (t, J = 7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ 141.5 (CR4), 
128.5 (2 × CH2), 128.4 (2 × CH2), 125.9 (CH), 86.0 (CR4), 80.9 (CR4), 62.0 (CH), 39.7 (CH2), 
31.5 (CH2), 30.7 (CH2), 21.9 (CH2), 18.3 (CH2), 13.6 (CH3); FTIR (thin film): ν 3334, 3063, 
3027, 2955, 2931, 2862, 2229, 1604, 1496, 1455, 1379, 1328, 1133, 1053, 1030, 915, 




2-Bromoundec-1-en-5-yn-4-ol. HBr (48% in H2O, 0.05 mL, 0.4 mmol, 10 mol%) and 2-
octynal (500 mg, 4.03 mmol) were successively added to a suspension of Sn powder 
(717 mg, 6.04 mmol) and 2,3-dibromopropene, 80 wt% (1.50 mL, 12.3 mmol) in Et2O 
(8.0 mL) and H2O (8.0 mL). The resulting mixture was stirred for 6 h before it was 
diluted with tert-butyl methyl ether (50 mL) and poured into H2O (50 mL). The aqueous 
phase was extracted with tert-butyl methyl ether (2 × 50 mL), the combined organic 
layers were dried over Na2SO4, filtered and concentrated under reduced pressure. 
Purification of the residue by flash chromatography (EtOAc/hexane 10:90 to 20:80; step 
gradient) afforded the title compound (792 mg, 97%) as a colorless oil. 1H NMR (400 
  
 
MHz, CDCl3): δ 5.74 (dt, J = 2.0, 1.1 Hz, 1H), 5.55 (d, J = 1.7 Hz, 1H), 4.68 (ddt, J = 7.6, 5.5, 
2.0 Hz, 1H), 2.81 (ddd, J = 14.5, 7.7, 0.9 Hz, 1H), 2.75 (ddd, J = 14.5, 5.6, 1.2 Hz, 1H), 2.20 
(td, J = 7.1, 2.0 Hz, 2H), 1.83 (s, 1H), 1.54-1.46 (m, 2H), 1.39-1.26 (m, 4H), 0.90 (app. t, J = 
7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ 128.7 (CR4), 120.2 (CH2), 86.7 (CR4), 79.5 (CR4), 
60.6 (CH), 49.9 (CH2), 31.0 (CH2), 28.2 (CH2), 22.2 (CH2), 18.6 (CH2), 14.0 (CH3); FTIR 
(thin film): ν 3339, 2957, 2932, 2860, 2230, 1632, 1459, 1429, 1341, 1202, 1145, 1116, 
1037, 890 cm−1; HRMS (ESI): exact mass calculated for C11H17O(79Br)Na [(M+Na)+] 




(Z)-1-Phenyl-4-(tributylstannyl)non-4-en-3-ol. Bu3SnH (3.75 mL, 13.9 mmol) was 
added dropwise over 1 h via syringe pump to a brown solution of 1-phenylnon-4-yn-3-ol 
(2.60 g, 12.0 mmol) and [(Cp*)RuCl2]n (110 mg, 0.358 mmol, 3 mol%) in CH2Cl2 (60 mL) 
at ambient temperature. The mixture was stirred for additional 0.5 h before it was 
concentrated under reduced pressure. Purification of the residue by flash 
chromatography (EtOAc/hexane 5:95 to 10:90; step gradient) afforded the title 
compound (5.62 g, 92%) as a faintly yellowish oil with a proximal/distal ratio of >99:1. 
1H NMR (400 MHz, CDCl3): δ 7.31-7.26 (m, 2H), 7.22-7.17 (m, 3H), 6.18 (td, J = 7.2, 1.1 Hz, 
1H), 4.15 (t, J = 6.8 Hz, 1H), 2.65 (qdd, J = 13.8, 9.8, 6.2 Hz, 2H), 2.05 (app. q, J = 7.2 Hz, 
2H), 189-1.66 (m, 2H), 1.60-1.41 (m, 7H), 1.41-1.25 (m, 10H), 1.04-0.82 (m, 18H); 
13C NMR (101 MHz, CDCl3): δ 147.5 (CR4), 142.2 (CR4), 141.2 (CH), 128.5 (2 × CH), 128.3 
(2 × CH), 125.7 (CH), 79.4 (CH), 39.3 (CH2), 34.0 (CH2), 32.3 (2 × CH2), 29.3 (3 × CH2), 
27.4 (3 × CH2), 22.6 (CH2), 14.1 (CH3), 13.7 (3 × CH3), 11.1 (3 × CH2); 119Sn NMR 
(149 MHz, CDCl3, 1H decoupling): δ −55.1; FTIR (thin film): ν 3463, 3063, 3027, 2955, 
2922, 2871, 2853, 1614, 1496, 1455, 1419, 1376, 1340, 1289, 1180, 1152, 1071, 1048, 
1030, 1001, 961, 925, 863, 767 cm−1; HRMS (ESI): exact mass calculated for C27H48OSnNa 





(Z)-2-Bromo-5-(tributylstannyl)undeca-1,5-dien-4-ol. Bu3SnH (1.20 mL, 4.46 mmol) 
was added over 1 h via syringe pump to a dark brown solution of 2-bromoundec-1-en-5-
yn-4-ol (973 mg, 3.97 mmol) and [(Cp*)RuCl2]n (36.0 mg, 0.117 mmol, 3 mol%) in CH2Cl2 
(20 mL) at ambient temperature. The resulting mixture was stirred for additional 0.5 h 
before it was concentrated under reduced pressure. Purification of the residue by flash 
chromatography (EtOAc/hexane 2:98 to 5:95 to 10:90; step gradient) afforded the title 
compound (1.62 g, 76%) as colorless oil with a proximal/distal ratio of 92:8. 1H NMR 
(400 MHz, CDCl3): δ 6.27 (td, J = 7.2, 1.1 Hz, 1H), 5.65 (d, J = 1.3 Hz, 1H), 5.51 (d, J = 1.6 
Hz, 1H), 4.50-4.46 (m, 1H), 2.57- 2.47 (m, 2H), 2.05-1.98 (m, 2H), 1.69 (d, J = 2.8 Hz, 1H), 
1.55-1.42 (m, 6H), 1.39-1.24 (m, 12H), 1.01-0.95 (m, 6H), 0.89 (t, J = 7.3 Hz, 12H); 
13C NMR (101 MHz, CDCl3): δ 145.5 (CR4), 141.7 (CH), 130.8 (CR4), 119.3 (CH2), 76.4 
(CH), 49.9 (CH2), 34.3 (CH2), 31.7 (CH2), 29.7 (CH2), 29.2 (3 × CH2), 27.4 (3 × CH2), 22.6 
(CH2) , 14.0 (CH3), 13.7 (3 × CH3), 11.1 (3 × CH2; 119Sn NMR (149 MHz, CDCl3, 1H 
decoupling): δ −54.0; FTIR (thin film): ν 3463, 2955, 2922, 2871, 2854, 1630, 1493, 
1463, 1420, 1376, 1290, 1197, 1147, 1116, 1071, 1020, 961, 883, 745, 698 cm−1; HRMS 
(ESI): exact mass calculated for C23H45OBrSnNa [(M+Na)+] 559.1567, found 559.1563. 
 
 
(E)-1-Phenylnon-4-en-3-ol (8). CuTC (20.0 mg, 105 µmol) was added to a solution of 
(Z)-1-phenyl-4-(tributylstannyl)non-4-en-3-ol (6) (50.0 mg, 98.5 µmol) and Ph2PO2NBu4 
(50.0 mg, 109 µmol) in DMF (0.50 mL) at ambient temperature and the resulting mixture 
was stirred for 2.5 h. The mixture was diluted with tert-butyl methyl ether (30 mL) and 
poured into a mixture of 25% aqueous NH4OH/sat. aqueous NH4Cl solution (1:9, 10 mL). 
The phases were separated and the aqueous layer extracted with tert-butyl methyl ether 
(2 × 30 mL). The combined organic extracts were dried over Na2SO4, filtered and 
concentrated under reduced pressure. Purification of the residue by flash 
  
 
chromatography (EtOAc/hexane 20:80) afforded the title compound (20.8 mg, 97%) as 
colorless oil. 1H NMR (400 MHz, CDCl3): δ 7.31-7.25 (m, 2H), 7.22-7.17 (m, 3H), 5.66 (dtd, 
J = 15.4, 6.7, 0.9 Hz, 1H), 5.50 (ddt, J = 15.4, 7.0, 1.4 Hz, 1H), 4.08 (q, J = 6.7 Hz, 1H), 2.76-
2.63 (m, 2H), 2.05 (q, J = 6.6 Hz, 2H), 1.93-1.76 (m, 2H), 1.46 (br s, 1H), 1.41- 1.26 (m, 
4H), 0.90 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ 142.0 (CR4), 132.7 (CH), 132.6 
(CH), 128.4 (2 × CH), 128.3 (2 × CH), 125.8 (CH), 72.5 (CH), 38.8 (CH2), 31.9 (CH2), 31.8 
(CH2), 31.3 (CH2), 22.2 (CH2), 13.9 (CH3); FTIR (thin film): ν 3358, 3063, 3027, 2956, 
2926, 2858, 1603, 1496, 1455, 1379, 1294, 1098, 1053, 1030, 970, 917, 746 cm−1; HRMS 
(ESI): exact mass calculated for C15H22ONa [(M+Na)+] 241.1563, found 241.1564. 
Representative Procedure for the trans-Hydrosilylation using Alkoxysilanes. (Z)-4-
(Diethoxymethylsilyl)-1-phenylnon-4-en-3-ol. Diethoxymethyl-
silane (650 mg, 4.8417 mmol) was added under argon to a stirred 
solution of 1-phenyldec-4-yn-3-ol (950 mg, 4.3916 mmol) and 
[Cp*RuCl]4 (60 mg, 0.05520 mmol) in CH2Cl2 (22 mL). Once the reaction was complete 
(ca. 15 min, TLC), CNCH2COOK (120 mg, 0.97 mmol) was added as catalyst scavenger, 
and stirring was continued for 2 hours. Insoluble matrials were filtered off and rinsed 
with CH2Cl2, the combined filtrates were evaporated under reduced pressure, and the 
residue was purified by filtration through a short pad of silica using hexanes/ethyl 
acetate 15:1 as the eluent to give the title compound as a pale yellow oil (942 mg, 61 %). 
1H NMR (400 MHz, CDCl3) δ 7.30-7.25 (m, 2H), 7.21-7.15 (m, 3H), 6.12 (t, J = 7.6 Hz, 1H), 
3.95 (m, 1H), 3.80 (m, 4H), 3.49 (d, J = 10.3 Hz, OH), 2.77-2.56 (m, 2H), 2.27-2.16 (m, 2H), 
2.06-1.95 (m, 1H), 1.87-1.76 (m, 1H), 1.43-1.29 (m, 4H), 1.24 (td, J = 5.0, 0.9 Hz, 6H), 0.91 
(m, 3H), 0.28 (s, 3H); 13C (101 MHz, CDCl3) δ 146.8, 142.5, 138.2, 128.4, 125.6, 79.6, 58.3, 
40.5, 32.8, 31.8, 31.3, 22.5, 18.18, 18.13, 14.0, -2.1; FTIR (thin film): ṽ 3496, 3026, 2958, 
2926, 2874, 1613, 1496, 1481, 1454, 1410, 1390, 1364, 1294, 1257, 1214, 1165, 1101, 
1071, 1031, 1006, 945, 876, 817, 792, 760, 698 cm-1; HRMS (ESI): exact mass calculated 
for C20H34O3SiNa (M+Na+) 373.2169, found 373.2173. 
(Z)-6-(Diethoxy(methyl)silyl)-7-hydroxy-9-phenylnon-5-enenitrile. Prepared 
analogously as a colorless oil (115 mg, 36 %). 1H NMR (400 MHz, 
CDCl3) δ 7.31-7.25 (m, 2H), 7.21-7.15 (m, 3H), 6.05 (t, J = 7.5 Hz, 
  
 
1H), 3.98 (m, 1H), 3.80 (m, 4H), 3.31 (d, J = 9.8 Hz, OH), 2.79-2.57 (m, 2H), 2.44-2.31 (m, 
4H), 2.05-1.93 (m, 1H), 1.87-1.70 (m, 3H), 1.25 (td, J = 5.0, 0.9 Hz, 6H), 0.29 (s, 3H); 13C 
(101 MHz, CDCl3) δ 142.7, 142.1, 141.3, 128.4, 125.7, 119.3, 78.9, 58.3, 40.1, 32.6, 30.2, 
25.4, 18.13, 18.11, 16.7, -2.2; FTIR (thin film): ṽ 3493, 3026, 2972, 2926, 2246, 1615, 
1496, 1454, 1424, 1390, 1365, 1293, 1259, 1164, 1101, 1069, 947, 792, 758, 699 cm-1; 
HRMS (ESI): exact mass calculated for C20H31NO3SiNa [(M+Na)+] 384.1965, found 
384.1966. 
Ethyl (2E,5Z)-5-(Diethoxy(methyl)silyl)-4-hydroxy-3-methyldeca-2,5-dienoate. 
Prepared analogously as a pale yellow oil (207 mg, 65 %). 1H NMR 
(400 MHz, CDCl3) δ 6.25 (t, J = 7.6 Hz, 1H), 6.05 (t, J = 1.4 Hz, 1H), 
4.42 (d, J = 10.0 Hz, 1H), 4.16 (q, J = 7.2 Hz, 2H), 4.10 (d, J = 9.8 Hz, 
OH), 3.82-3.70 (m, 4H), 2.26 (m, 2H), 2.03 (s, 3H), 1.44-1.30 (m, 4H), 1.27 (t, J = 7.1 Hz, 
3H), 1.23 (td, J = 7.0, 0.9 Hz, 6H), 0.91 (m, 3H), 0.20 (s, 3H); 13C (101 MHz, CDCl3) δ 167.1, 
159.8, 150.1, 134.9, 114.6, 83.1, 59.5, 58.5, 31.7, 31.3, 22.5, 18.0, 16.3, 14.3, 14.0, -2.4; 
FTIR (thin film): ṽ 3466, 2973, 2926, 2875, 1716, 1651, 1612, 1443, 1390, 1366, 1342, 
1258, 1207, 1142, 1100, 1071, 1044, 948, 876, 821, 801, 762, 681 cm-1; HRMS (ESI): 
exact mass calculated for C18H34O5SiNa [(M+Na)+] 381.2068, found 381.2068. 
(Z)-4-(Cyclohex-1-en-1-yl)-3-(diethoxy(methyl)silyl)but-3-en-2-ol. Prepared 
analogously as a pale yellow oil (164 mg, 47 %). 1H NMR (400 MHz, 
CDCl3) δ 6.54 (s, 1H), 5.75 (m, 1H), 4.24 (m, 1H), 3.85-3.74 (m, 5H), 2.06 
(m, 2H), 2.00 (m, 2H), 1.68-1.50 (m, 4H), 1.36 (d, J = 6.6 Hz, 3H), 1.24 (m, 
6H), 0.24 (s, 3H); 13C (101 MHz, CDCl3) δ 147.0, 139.5, 136.6, 126.6, 75.5, 58.3, 58.2, 28.1, 
25.4, 24.7, 22.5, 21.9, 18.1, -2.5; FTIR (thin film): ṽ 3448, 2971, 2925, 2833, 1597, 1438, 
1390, 1364, 1294, 1255, 1164, 1102, 1070, 942, 895, 859, 838, 797, 756, 730, 684 cm-1; 
HRMS (ESI): exact mass calculated for C15H28O3SiNa [(M+Na)+] 307.1700, found 
307.1702. 
(Z)-3-(Diethoxy(methyl)silyl)-2-methyl-6-phenylhex-3-en-2-ol. Prepared 
analogously as a colorless oil (180 mg, 90 %). 1H NMR (400 MHz, 
CDCl3) δ 7.31-7.25 (m, 2H), 7.21-7.15 (m, 3H), 6.21 (t, J = 7.5 Hz, 1H), 
4.32 (s, OH), 3.77 (m, 4H), 2.69 (m, 2H), 2.54 (m, 2H), 1.35 (s, 6H), 
1.23 (t, J = 6.8 Hz, 6H), 0.22 (s, 3H); 13C (101 MHz, CDCl3) δ 143.9, 141.5, 140.7, 128.5, 
  
 
128.3, 125.9, 74.0, 58.2, 36.1, 33.2, 30.1, 18.1, -1.9; FTIR (thin film): ṽ 3497, 3086, 3063, 
3027, 2972, 2926, 2883, 1605, 1496, 1482, 1454, 1390, 1369, 1294, 1258, 1209, 1163, 
1100, 1069, 998, 944, 881, 790, 752, 698 cm-1; HRMS (ESI): exact mass calculated for 
C18H30O3SiNa [(M+Na)+] 345.1856, found 345.1857. 
(Z)-4-(2-(Diethoxy(methyl)silyl)-3-hydroxy-3-methylbut-1-en-1-yl)benzaldehyde. 
Prepared analogously as a yellow oil that has to be used without 
delay  (118 mg, 88 %). 1H NMR (400 MHz, CDCl3) δ 10.00 (s, 1H), 
7.83 (m, 2H), 7.47 (m, 2H), 7.31 (s, 1H), 4.44 (s, OH), 3.72 (m, 4H), 
1.49 (s, 6H), 1.16 (t, J = 7.0 Hz, 6H), -0.05 (s, 3H); 13C (101 MHz, CDCl3) δ 191.8, 150.8, 
145.6, 139.9, 135.2, 129.31, 129.16, 74.9, 58.4, 30.5, 18.0, -2.0; FTIR (thin film): ṽ 3483, 
2973, 2927, 2884, 2838, 2733, 1697, 1602, 1565, 1482, 1443, 1389, 1363, 1305, 1260, 
1208, 1166, 1102, 1067, 949, 889, 866, 813, 794, 777, 758, 688 cm-1; HRMS (ESI): exact 
mass calculated for C17H26O4SiNa [(M+Na)+] 345.1493, found 345.1495. 
 




Representative Procedure for the C-Methylation of Alkenylstannanes. Method A 
(Copper/Palladium Co-Catalysis): (E)-4-Methyl-1-phenylnon-4-en-3-ol (7). To a 
clear, colorless solution of (Z)-1-phenyl-4-(tributylstannyl)non-4-en-3-ol (6) 
(254 mg, 501 µmol) and (Ph2PO2)NBu4 (250 mg, 544 µmol) in DMF (2.5 mL) at 
ambient temperature was added Pd(PPh3)4 (30.0 mg, 26 µmol, 5 mol%) and the 
resulting yellow mixture was stirred until complete dissolution had occurred, 
usually ca. 5 min. After that time, MeI (48 µL, 770 µmol) was added, immediately 
followed, within max. 30 seconds, by CuTC (100 mg, 524 µmol). The resulting black 
suspension was stirred for 0.5 h before the reaction was quenched by the addition 
  
 
of Et3N (ca. 0.1 mL). The mixture was diluted with tert-butyl methyl ether (30 mL), 
poured on a mixture of 25% aqueous NH4OH/sat. aqueous NH4Cl solution (1:9, 
20 mL), the phases were separated and the bright blue aqueous phase extracted 
with tert-butyl methyl ether (2 × 30 mL). The combined organic extracts were 
dried over Na2SO4, filtered and concentrated under reduced pressure. Purification 
of the residue by flash chromatography (EtOAc/hexane 10:90 to 20:80; step 
gradient) afforded the methylated product 7 (107 mg, 92%) as a faintly yellowish 
oil with a methylation/protodestannation ratio of 7:8 = 97:3, as determined by 1H 
NMR and GCMS. 1H NMR (400 MHz, CDCl3): δ 7.32-7.25 (m, 2H), 7.23-7.16 (m, 3H), 
5.41 (t, J = 7.1 Hz, 1H), 4.02 (t, J = 6.7 Hz, 1H), 2.71-2.55 (m, 2H), 2.04 (q, J = 7.0 Hz, 
2H), 1.95-1.79 (m, 2H), 1.63 (s, 3H), 1.46 (br s, 1H), 1.40-1.26 (m, 4H), 0.91 (app. t, 
J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ 142.1 (CR4), 136.7 (CR4), 128.4 
(2 × CH), 128.3 (2 × CH), 127.3 (CH), 125.7 (CH), 77.4 (CH), 36.5 (CH2), 32.2 (CH2), 
31.7 (CH2), 27.2 (CH2), 22.4 (CH2), 14.0 (CH3), 11.2 (CH3); FTIR (thin film): ν 3348, 
3027, 2955, 2927, 2858, 1496, 1455, 1378, 1298, 1052, 1030, 998, 918, 851, 747, 





Representative Procedure for the Methylation of Alkenylstannanes. Method B 
(CuTC Only): (E)-4-Methyl-1-phenylnon-4-en-3-ol (7). To a clear, colorless 
solution of (Z)-1-phenyl-4-(tributylstannyl)non-4-en-3-ol (6) (254 mg, 501 µmol) 
and (Ph2PO2)NBu4 (250 mg, 544 µmol) in DMSO (2.5 mL) at ambient temperature 
was added MeI (95 µL, 1500 µmol), immediately followed, within maximum 30 
seconds, by CuTC (100 mg, 524 µmol). The resulting black suspension was stirred 
for 1 hour before the reaction was quenched by the addition of Et3N (ca. 0.1 mL). 
  
 
The mixture was diluted with tert-butyl methyl ether (30 mL) and poured on a 
mixture of 25% aqueous NH4OH/sat. aqueous NH4Cl solution (1:9, 20 mL). The 
phases were separated and the clear, bright blue aqueous phase was extracted 
with tert-butyl methyl ether (2 × 30 mL). The combined organic extracts were 
dried over Na2SO4, filtered and concentrated under reduced pressure. Purification 
of the residue by flash chromatography (EtOAc/hexane 10:90 to 20:80; step 
gradient) afforded the desired methylated product 7 (99.4 mg, 85%) as a colorless 
oil with a methylation/protodestannation ratio 7:8 = 99:1, as determined by 1H 
NMR and GCMS. Analytical and spectral data as described above. 
(E)-2,3-Dimethyl-6-phenylhex-3-en-2-ol. Prepared according to method B as a 
colorless oil (78.2 mg, 76%) with a methylation/protodestannation 
ratio of 94:6, as determined by 1H NMR and GCMS.  
The same product was prepared according to method A as a colorless 
oil (89.8 mg, 88%) with a methylation/protodestannation ratio of 79:21, as determined 
by 1H NMR and GCMS. 1H NMR (400 MHz, CDCl3): δ 7.33-7.27 (m, 2H), 7.24-7.18 (m, 3H), 
5.58 (td, J = 7.1, 1.3 Hz, 1H), 2.71 (dd, J = 8.8, 6.8 Hz, 2H), 2.36 (app. q, J = 7.4 Hz, 2H), 1.63 
(br s, 4H), 1.33 (s, 6H); 13C NMR (101 MHz, CDCl3): δ 142.1 (CR4), 141.9 (CR4), 128.4 
(2 × CH), 128.1 (2 × CH), 125.6 (CH), 121.1 (CH), 73.3 (CR4), 35.8 (CH2), 29.8 (CH2), 28.8 
(2 × CH3), 12.6 (CH3); FTIR (thin film): ν 3384, 3026, 2974, 2927, 2858, 1603, 1496, 
1453, 1370, 1258, 1136, 1075, 1030, 1001, 935, 850, 746, 697 cm–1; HRMS (ESI): exact 
mass calculated for C14H20ONa [(M+Na)+] 227.1406, found 227.1404. 
(3E,6E)-6-Methylundeca-3,6-dien-5-ol. Prepared according to method B as a colorless 
oil (65.8 mg, 72%) with a methylation/protodestannation ratio 
of 95:5, as determined by 1H NMR and GCMS. 1H NMR (400 MHz, 
CDCl3): δ 5.72 (dtd, J = 15.4, 6.3, 1.2 Hz, 1H), 5.46 (ddt, J = 15.4, 
6.8, 1.5 Hz, 2H), 4.45 (d, J = 6.5 Hz, 1H), 2.13-1.98 (m, 4H), 1.59 (s, 3H), 1.56 (br s, 1H), 
1.39-1.24 (m, 4H), 0.99 (t, J = 7.5 Hz, 3H), 0.89 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, 
CDCl3): δ 136.3 (CR4), 133.9 (CH), 130.0 (CH), 126.3 (CH), 78.2 (CH), 31.7 (CH2), 27.3 
(CH2), 25.3 (CH2), 22.4 (CH2), 14.0 (CH3), 13.4 (CH3), 12.1 (CH3); FTIR (thin film): ν 3352, 
  
 
2959, 2926, 2872, 2857, 1459, 1378, 1297, 1084, 1004, 965, 850 cm−1; HRMS (ESI): exact 
mass calculated for C12H22ONa [(M+Na)+] 205.1563, found 205.1563. 
(E) - 1 - (Cyclohex-1-en-1-yl) - 2,4 - dimethylpent - 1 - en -3-ol. Prepared according to 
method B as a colorless oil (76.8 mg, 79%) with a methylation/proto-
destannation ratio of 90:10, as determined by 1H NMR and GCMS. 
1H NMR (400 MHz, CDCl3): δ 5.73 (br s, 1H), 5.59 (app. dt, J = 3.9, 2.0 Hz, 
1H), 3.58 (d, J = 8.1 Hz, 1H), 2.09 (dq, J = 6.6, 2.7 Hz, 4H), 1.82-1.72 (m, 1H), 1.74 (d, J = 
1.2 Hz, 3H), 1.67-1.53 (m, 5H), 0.98 (d, J = 6.6 Hz, 3H), 0.80 (d, J = 6.8 Hz, 3H); 13C NMR 
(101 MHz, CDCl3): δ 136.1 (CR4), 134.8 (CR4), 129.9 (CH), 127.1 (CH), 84.7 (CH), 31.3 
(CH), 29.3 (CH2), 25.6 (CH2), 22.9 (CH2), 22.2 (CH2), 19.5 (CH3), 18.6 (CH3), 13.2 (CH3); 
FTIR (thin film): ν 3387, 2925, 2869, 2833, 1447, 1379, 1365, 1295, 1242, 1169, 1132, 
1009, 923, 885, 801 cm–1; HRMS (ESI): exact mass calculated for C13H22ONa [(M+Na)+] 
217.1563, found 217.1563. 
(E)-4-(3-Hydroxy-2,3-dimethylbut-1-en-1-yl) benzonitrile. Prepared according to 
method B as a colorless oil (87.2 mg, 86%) with a 
methylation/protodestannation ratio of 99:1, as determined by 1H 
NMR and GCMS. 1H NMR (400 MHz, CDCl3): δ 7.59 (d, J = 8.4 Hz, 2H), 
7.32 (d, J = 8.1 Hz, 2H), 6.69 (d, J = 1.6 Hz, 1H), 1.87 (d, J = 1.3 Hz, 3H), 1.70 (s, 1H), 1.43 
(s, 6H); 13C NMR (101 MHz, CDCl3): δ 148.0 (CR4), 143.4 (CR4), 131.8 (2 × CH), 129.6 
(2 × CH), 121.1 (CH), 119.1 (CR4), 109.5 (CR4), 73.9 (CR4), 28.9 (2 × CH3), 14.7 (CH3); 
FTIR (thin film): ν 3430, 2975, 2931, 2871, 2226, 1642, 1603, 1502, 1462, 1446, 1408, 
1363, 1240, 1211, 1170, 1115, 959, 941, 879, 821 cm–1; HRMS (ESI): exact mass 
calculated for C13H15NONa [(M+Na)+] 224.1046, found 224.1044. 
(E)-7-Hydroxy-6-methyl-9-phenylnon-5-enenitrile. Prepared according to method B 
as a colorless oil (98.8 mg, 81%) with a methylation/protode-
stannation ratio of 99:1, as determined by 1H NMR and GCMS. 
1H NMR (400 MHz, CDCl3): δ 7.24-7.16 (m, 2H), 7.14-7.09 (m, 
3H), 5.29 (app. tp, J = 7.3, 1.2 Hz,1H), 3.96 (t, J = 6.6 Hz, 1H), 2.62 (ddd, J = 13.8, 9.4, 6.4 
Hz, 1H), 2.52 (ddd, J = 13.8, 9.1, 6.9 Hz, 1H), 2.27 (t, J = 7.1 Hz, 2H), 2.15 (app. q, J = 7.3 
Hz, 2H), 1.79 (dddd, J = 9.2, 6.8, 6.1, 4.9 Hz, 2H), 1.67 (p, J = 7.2 Hz, 2H), 1.58 (app. t, J = 
1.1 Hz, 3H), 1.48 (br s, 1H); 13C NMR (101 MHz, CDCl3): δ 141.8 (CR4), 139.6 (CR4), 128.4 
  
 
(4 × CH), 125.8 (CH), 123.7 (CH), 119.7 (CR4), 76.9 (CH), 36.6 (CH2), 32.1 (CH2), 26.4 
(CH2), 25.1 (CH2), 16.6 (CH2), 11.7 (CH3); FTIR (thin film): ν 3428, 3026, 2929, 2860, 
2247, 1603, 1495, 1454, 1304, 1156, 1055, 1030, 1008, 918, 870, 749, 700 cm–1; HRMS 
(ESI): exact mass calculated for C16H21NONa [(M+Na)+] 266.1515, found 266.1514. 
(E)-1-Cyclohexyl-2-methylhept-2-en-1-ol. Prepared according to method B as a 
colorless oil (86.4 mg, 82%) with a methylation/protodestannation 
ratio of >99:1, as determined by 1H NMR and GCMS. 1H NMR 
(400 MHz, CDCl3): δ 5.32 (ddq, J = 8.3, 5.8, 1.2 Hz, 1H), 3.61 (d, J = 
8.3 Hz, 1H), 2.05-1.96 (m, 3H), 1.80-1.60 (m, 3H), 1.57 (app. q, J = 1.0 Hz, 3H), 1.48-1.07 
(m, 10H), 0.99-0.78 (m, 5H); 13C NMR (101 MHz, CDCl3): δ 135.9 (CR4), 128.3 (CH), 83.3 
(CH), 40.6 (CH), 31.7 (CH2), 29.6 (CH2), 29.3 (CH2), 27.2 (CH2), 26.5 (CH2), 26.2 (CH2), 
26.0 (CH2), 22.4 (CH2), 14.0 (CH3), 11.1 (CH3); FTIR (thin film): ν 3360, 2955, 2920, 2851, 
1449, 1378, 1306, 1290, 1260, 1206, 1081, 1054, 1008, 891, 851 cm–1; HRMS (ESI): exact 
mass calculated for C14H26ONa [(M+Na)+] 233.1876, found 233.1873. 
(E) - 4 - (3-Hydroxy - 2,3 - dimethylbut-1-en-1-yl)benzaldehyde. Prepared according 
to method B as a colorless oil (87.1 mg, 85%) with a 
methylation/protodestannation ratio of 98:2, as determined by 1H 
NMR and GCMS.  
The same compound was prepared according to method A as a colorless oil (82.9 mg, 
81%) with a methylation/protodestannation ratio of 98:2, as determined by 1H NMR and 
GCMS. 1H NMR (400 MHz, CDCl3): δ 9.95 (s, 1H), 7.80 (d, J = 8.3 Hz, 2H), 7.37 (d, 
J = 8.2 Hz, 2H), 6.71 (s, 1H), 1.97 (s, 1H), 1.89 (d, J = 1.4 Hz, 3H), 1.43 (s, 6H); 13C NMR 
(101 MHz, CDCl3): δ 191.9 (CH), 147.7 (CR4), 145.1 (CR4), 134.1 (CR4), 129.5 (4 × CH), 
121.5 (CH), 73.8 (CR4), 28.9 (2 × CH3), 14.8 (CH3); FTIR (thin film): ν 3434, 2974, 2930, 
2831, 2735, 1687, 1646, 1599, 1563, 1462, 1445, 1416, 1362, 1306, 1212. 1166, 1112, 
978, 959, 941, 879, 825, 788, 745 cm–1; HRMS (ESI): exact mass calculated for 
C13H16O2Na [(M+Na)+] 227.1042, found 227.1041. 
Ethyl (2E,5E)-4-hydroxy-3,5-dimethyldeca-2,5-dienoate. Prepared according to 
method B as a colorless oil (99.5 mg, 83%) with a 
methylation/protodestannation ratio of 97:3, as determined by 
  
 
1H NMR and GCMS.  
The same compound was prepared according to method A as a colorless oil (106 mg, 
88%) with a methylation/protodestannation ratio of 95:5, as determined by 1H NMR and 
GCMS. 1H NMR (400 MHz, CDCl3): δ 6.08 (p, J = 1.4 Hz, 1H), 5.53 (t, J = 7.2 Hz, 1H), 4.44 (s, 
1H), 4.15 (qd, J = 7.1, 1.3 Hz, 2H), 2.04 (q, J = 7.3 Hz, 2H), 1.99 (d, J = 1.4 Hz, 3H), 1.87 (d, J 
= 2.6 Hz, 1H), 1.49 (d, J = 1.2 Hz, 3H), 1.41-1.22 (m, 7H), 0.89 (t, J = 7.1 Hz, 3H); 13C NMR 
(101 MHz, CDCl3): δ 166.9 (CR4), 157.7 (CR4), 133.7 (CR4), 130.3 (CH), 115.0 (CH), 81.6 
(CH), 59.7 (CH2), 31.5 (CH2), 27.4 (CH2), 22.3 (CH2), 15.5 (CH3), 14.3 (CH3), 13.9 (CH3), 
11.1 (CH3); FTIR (thin film): ν 3475, 2957, 2928, 2859, 1716, 1698, 1446, 1367, 1342, 
1280, 1211, 1144, 1042, 995, 892 cm–1; HRMS (ESI): exact mass calculated for 
C14H24O3Na [(M+Na)+] 263.1618, found 263.1615. 
(E)-2-Bromo-5-methylundeca-1,5-dien-4-ol. Prepared according to method B as a 
colorless oil (94.5 mg, 72%) with a methylation/protode-
stannation ratio of 97:3, as determined by 1H NMR and GCMS. 
1H NMR (400 MHz, CDCl3): δ 5.68 (q, J = 1.2 Hz, 1H), 5.53-5.47 (m, 
2H), 4.35 (dd, J = 8.1, 5.0 Hz, 1H), 2.68-2.56 (m, 2H), 2.01 (q, J = 7.2 Hz, 2H), 1.68 (br s, 
1H), 1.63 (s, 3H), 1.40-1.22 (m, 6H), 0.88 (t, J = 6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ 
135.2 (CR4), 130.7 (CR4), 127.8 (CH), 119.3 (CH2), 74.9 (CH), 47.4 (CH2), 31.5 (CH2), 29.1 
(CH2), 27.5 (CH2), 22.6 (CH2), 14.1 (CH3), 11.6 (CH3); FTIR (thin film): ν 3379, 2956, 
2924, 2856, 1632, 1458, 1378, 1300, 1200, 1115, 1017, 885, 570 cm–1; HRMS (ESI): exact 
mass calculated for C12H21OBrNa [(M+Na)+] 283.0668, found 283.0665. 
(E)-6-Chloro-2-methylhex-2-en-1-ol. Prepared according to method B as a colorless oil 
(49.8 mg, 67%) with a methylation/protodestannation ratio of 98:2, 
as determined by 1H NMR and GCMS. 1H NMR (400 MHz, CDCl3): δ 
5.37 (tdd, J = 7.3, 2.6, 1.3 Hz, 1H), 3.99 (s, 2H), 3.52 (t, J = 6.6 Hz, 2H), 2.19 (q, J = 7.1 Hz, 
2H), 1.83 (p, J = 6.7 Hz, 2H), 1.68 (br s, 1H), 1.67 (s, 3H); 13C NMR (101 MHz, CDCl3): δ 
136.3 (CR4), 123.9 (CH), 68.7 (CH2), 44.5 (CH2), 32.2 (CH2), 24.7 (CH2), 13.7 (CH3); FTIR 
(thin film): ν 3322, 2935, 2917, 2862, 1443, 1385, 1346, 1308, 1287, 1230, 1065, 1038, 
1007, 861, 844, 746, 723 cm–1; HRMS (ESI): exact mass calculated for C7H13O(35Cl)Na 





according to method B as a colorless oil (144 mg, 76%) with a 
methylation/protodestannation ratio of 96:4, as determined 
by 1H NMR and GCMS. 1H NMR (400 MHz, CDCl3): δ 7.83 (dd, J 
= 5.4, 3.1 Hz, 2H), 7.70 (dd, J = 5.5, 3.1 Hz, 2H), 7.29-7.24 (m, 2H), 7.20-7.14 (m, 3H), 5.37 
(t, J = 7.1 Hz, 1H), 4.01 (t, J = 6.7 Hz, 1H), 3.68 (t, J = 7.3 Hz, 2H), 2.67 (ddd, J = 13.8, 9.8, 
6.2 Hz, 1H), 2.57 (ddd, J = 13.9, 9.5, 6.5 Hz, 1H), 2.09 (br q, J = 7.4 Hz, 2H), 1.94-1.75 (m, 
2H), 1.74-1.63 (m, 3H), 1.62 (s, 3H), 1.43 (p, J = 7.4 Hz, 2H); 13C NMR (101 MHz, CDCl3): δ 
168.4 (2 × CR4), 142.1 (CR4), 137.6 (CR4), 133.8 (2 × CR4), 132.1 (2 × CH), 128.4 (2 × CH), 
128.3 (2 × CH), 126.2 (CH), 125.7 (CH), 123.1 (2 × CH), 77.3 (CH), 37.8 (CH2), 36.4 (CH2), 
32.1 (CH2), 28.0 (CH2), 26.9 (CH2), 26.5 (CH2), 11.3 (CH3); FTIR (thin film): ν 3467, 3061, 
3026, 2937, 2859, 1770, 1705, 1604, 1495, 1467, 1453, 1437, 1396, 1369, 1337,.1188, 
1037, 920, 892, 867, 749, 719, 700 cm–1; HRMS (ESI): exact mass calculated for 
C24H27NO3Na [(M+Na)+] 400.1883, found 400.1880. 
(E)-5-Methyl-1-phenyldec-5-en-3-ol. Prepared from (Z)-1-phenyl-5-
(tributylstannyl)dec-5-en-3-ol (86:15 mixture of pro-
ximal/distal vinyl stannane, 261 mg, 501 µmol) according to 
method A as a faintly yellowish oil (85:15 mixture of proximal/distal product, 103 mg, 
84%) with a methylation/protodestannation ratio of 92:8, as determined by 1H NMR and 
GCMS. 1H NMR (87:13 mixture of proximal/distal product, only resonances of the major 
isomer are reported, 400 MHz, CDCl3): δ 7.33-7.26 (m, 2H), 7.24-7.15 (m, 3H), 5.27 (tq, J 
= 7.2, 1.3 Hz, 1H), 3.71 (dtd, J = 9.6, 6.1, 3.7 Hz, 1H), 2.90-2.77 (m, 1H), 2.71 (dt, J = 13.7, 
8.1 Hz, 1H), 2.23 (dd, J = 13.2, 3.3 Hz, 1H), 2.12-1.96 (m, 3H), 1.85-1.66 (m, 3H), 1.62 (d, J 
= 1.2 Hz, 3H), 1.40-1.24 (m, 4H), 0.95-0.85 (m, 3H); 13C NMR (87:13 mixture of 
proximal/distal product, only resonances of the major isomer are reported,101 MHz, 
CDCl3): δ 142.3 (CR4), 131.6 (CR4), 129.2 (CH), 128.4 (2 × CH), 128.3 (2 × CH), 125.7 (CH), 
67.7 (CH), 48.1 (CH2), 38.7 (CH2), 32.2 (CH2), 31.9 (CH2), 27.7 (CH2), 22.4 (CH2), 16.0 
(CH3), 14.0 (CH3); FTIR (thin film): ν 3375, 3062, 3026, 2954, 2925, 2857, 1603, 1495, 
1454, 1380, 1266, 1181, 1079, 1050, 1029, 929, 840, 745, 698 cm–1; HRMS (ESI): exact 
mass calculated for C17H30NO [(M+NH4)+] 264.2322, found 264.2318. 
  
 
(2SR,3SR,E)-3,4-Dimethylnon-4-en-2-ol. Prepared from (2SR,3RS,Z)-3-methyl-4-
(tributylstannyl)non-4-en-2-ol (94:6 mixture of proximal/distal 
vinyl stannane, 224 mg, 503 µmol) according to method A as a 
faintly yellowish oil (94:6 mixture of proximal/distal product, 
72.2 mg, 84%) with a methylation/protodestannation ratio of 94:6, as determined by 1H 
NMR and GCMS. 1H NMR (94:6 mixture of proximal/distal product, only resonances of 
the major isomer are reported, 400 MHz, CDCl3): δ 5.21 (tp, J = 7.1, 1.3 Hz, 1H), 3.72 (p, J 
= 6.3 Hz, 1H), 2.08-1.96 (m, 3H), 1.57 (s, 3H), 1.47 (br s, 1H), 1.37-1.26 (m, 4H), 1.13 (d, J 
= 6.3 Hz, 3H), 1.04 (d, J = 7.0 Hz, 3H), 0.94-0.83 (m, 3H); 13C NMR (94:6 mixture of 
proximal/distal product, only resonances of the major isomer are reported, 101 MHz, 
CDCl3): 137.0 (CR4), 126.3 (CH), 69.2 (CH), 49.7 (CH), 31.9 (CH2), 27.4 (CH2), 22.4 (CH2), 
21.2 (CH3), 14.4 (CH3), 13.99 (CH3), 13.95 (CH3); FTIR (thin film): ν 3362, 2959, 2926, 
2873, 2859, 1455, 1372, 1298, 1249, 1157, 1081, 1026, 972, 952, 908, 850, 727 cm–1; 
HRMS (ESI): exact mass calculated for C11H22ONa [(M+Na)+] 193.1563, found 193.1563. 
(1RS,2SR)-2-((E)-Hept-2-en-2-yl)cyclohexan-1-ol. Prepared from (1RS,2RS)-2-((Z)-1-
(tributylstannyl)hex-1-en-1-yl)cyclohexan-1-ol (85:15 mixture of 
proximal/ distal vinyl stannane, 236 mg, 501 µmol) according to 
method A as a faintly yellowish oil (87:13 mixture of proximal/distal 
product, 59.7 mg, 61%) with a methylation/protodestannation ratio of 94:6, as 
determined by 1H NMR and GCMS. 1H NMR (87:13 mixture of proximal/distal product, 
only resonances of the major isomer are reported, 400 MHz, CDCl3): δ 5.32 (ddd, J = 8.6, 
6.3, 1.5 Hz, 1H), 3.40 (td, J = 10.0, 4.2 Hz, 1H), 2.12-1.97 (m, 3H), 1.88-1.59 (m, 5H), 1.56 
(d, J = 1.3 Hz, 3H), 1.40-1.12 (m, 8H), 0.89 (t, J = 7.1 Hz, 3H); 13C NMR (87:13 mixture of 
proximal/distal product, only resonances of the major isomer are reported, 101 MHz, 
CDCl3): 135.3 (CR4), 128.6 (CH), 70.2, 56.3, 34.0, 31.9, 30.0, 27.4, 25.7, 24.9, 22.4, 14.0, 
12.5; δ 142.3 (CR4), 131.6 (CR4), 129.2 (CH), 128.4 (2 × CH), 128.3 (2 × CH), 125.7 (CH), 
67.7 (CH), 48.1 (CH2), 38.7 (CH2), 32.2 (CH2), 31.9 (CH2), 27.7 (CH2), 22.4 (CH2), 16.0 
(CH3), 14.0 (CH3); FTIR (thin film): ν 3441, 2954, 2926, 2856, 1449, 1379, 1352, 1270, 
1132, 1106, 1063, 1042, 1008, 945, 843 cm–1; HRMS (ESI): exact mass calculated for 
C13H25O [(M+H)+] 197.1900, found 197.1899. 
  
 
(1RS,2SR)-2-((E)-Hept-2-en-2-yl)cyclopentan-1-ol. Prepared from (1RS,2RS)-2-((Z)-
1-(tributylstannyl)hex-1-en-1-yl)cyclopentan-1-ol (85:15 mixture of 
proximal/ distal vinyl stannane, 229 mg, 501 µmol) according to 
method A as a faintly yellowish oil (86:14 mixture of proximal/distal product, 60.4 mg, 
66%) with a methylation/protodestannation ratio of 98:2, as determined by 1H NMR and 
GCMS. 1H NMR (86:14 mixture of proximal/distal product, only resonances of the major 
isomer are reported, 400 MHz, CDCl3): δ 5.25 (tp, J = 7.1, 1.3 Hz, 1H), 3.96 (q, J = 7.4 Hz, 
1H), 2.24 (dt, J = 10.3, 7.8 Hz, 1H), 1.99 (ddt, J = 12.8, 10.3, 7.3 Hz, 3H), 1.83-1.45 (m, 6H), 
1.58 (s, 3H), 1.39-1.24 (m,4H), 0.89 (t, J = 7.1 Hz, 3H); 13C NMR (86:14 mixture of 
proximal/distal product, only resonances of the major isomer are reported,101 MHz, 
CDCl3): δ 134.7 (CR4), 126.2 (CH), 75.7 (CH), 57.8 (CH), 33.6 (CH2), 32.0 (CH2), 28.2 (CH2), 
27.6 (CH2), 22.4 (CH2), 21.3 (CH2), 14.0 (CH3), 13.3 (CH3); FTIR (thin film): ν 3336, 2955, 
2926, 2871, 1453, 1378, 1341, 1299, 1247, 1151, 1086, 1050, 975, 937, 838, 727 cm–1; 
HRMS (ESI): exact mass calculated for C12H23O [(M+H)+] 183.1743, found 183.1743. 
(E)-7-Methyltetradec-7-ene-1,14-diyl dihexanoate. Prepared according to method A 
as a colorless oil (164 mg, 75%) with a 
methylation/protodestannation ratio of >99:1, as 
determined by 1H NMR and GCMS. 1H NMR (400 MHz, CDCl3): δ 5.08 (t, J = 6.7 Hz, 1H), 
4.04 (t, J = 6.7 Hz, 4H), 2.27 (t, J = 7.5 Hz, 4H), 1.95 (app. q, J = 7.7 Hz, 4H), 1.60 (tt, J = 7.6, 
4.1 Hz, 8H), 1.56 (s, 3H), 1.42-1.22 (m, 20H), 0.88 (t, J = 6.8 Hz, 6H); 13C NMR (101 MHz, 
CDCl3): δ 173.9 (2 × CR4), 135.0 (CR4), 124.4 (CH), 64.3 (2 × CH2), 39.5 (CH2), 34.3 
(2 × CH2), 31.3 (2 × CH2), 29.7 (CH2), 28.87 (CH2), 28.83 (CH2), 28.6 (2 × CH2), 27.78 
(CH2), 27.74 (CH2), 25.83 (CH2), 25.80 (CH2), 24.7 (2 × CH2), 22.3 (2 × CH2), 15.8 (CH3), 
13.9 (2 × CH3); FTIR (thin film): ν 2954, 2928, 2857, 1735, 1463, 1381, 1355, 1244, 1169, 
1099, 1067, 944, 889, 851, 729 cm–1; HRMS (ESI): exact mass calculated for C27H50O4Na 











yl)oxy)silane (10d). LiOtBu (0.9 M in 2-Me-THF, 0.33 mL, 300 µmol) was added to a 
suspension of CuI (58.0 mg, 305 µmol) in DMF (0.50 mL) at 0 °C, the cooling bath was 
removed and the resulting dark brown solution was stirred at ambient temperature for 
30 min. A solution of (Z)-1-phenyl-4-(triethoxysilyl)non-4-en-3-ol (9d) (38.0 mg, 
99.8 µmol) in DMF (0.6 mL) was added, immediately followed by MeI (19.0 µL, 
305 µmol). The resulting mixture was stirred until TLC control showed complete 
conversion of the substrate before the reaction was quenched with Et3N (0.1 mL). The 
mixture was diluted with tert-butyl methyl ether (30 mL) and poured into a mixture of 
25% aqueous NH4OH/sat. aqueous NH4Cl solution (1:9, 10 mL). The aqueous phase was 
extracted with tert-butyl methyl ether (2 × 30 mL), the combined extracts were washed 
with brine (3 x) and then dried over Na2SO4, filtered and concentrated under reduced 
pressure, and the residue was purified by flash chromatography (EtOAc/hexane 2:98 to 
10:90; step gradient) to give the title compound (27.2 mg, 69%) as colorless oil. 1H NMR 
(400 MHz, CDCl3): δ 7.30-7.24 (m, 2H), 7.22-7.14 (m, 3H), 5.39 (t, J = 7.1 Hz, 1H), 4.27 (t, J 
= 6.7 Hz, 1H), 3.82 (q, J = 7.0 Hz, 6H), 2.66-2.48 (m, 2H), 2.03 (q, J = 7.0 Hz, 2H), 1.99-1.89 
(m, 1H), 1.82 (dddd, J = 13.3, 10.2, 6.5, 5.7 Hz, 1H), 1.61 (s, 3H), 1.39-1.28 (m, 4H), 1.21 (t, 
J = 7.0 Hz, 9H), 0.94-0.87 (m, 3H); 13C NMR (101 MHz, CDCl3): δ 142.4 (CR4), 135.7 (CR4), 
128.4 (2 × CH), 128.2 (2 × CH), 127.1 (CH), 125.6 (CH), 78.7 (CH), 59.1 (3 × CH2), 37.3 
(CH2), 32.0 (CH2), 31.7 (CH2), 27.2 (CH2), 22.4 (CH2), 18.1 (3 × CH3), 14.0 (CH3), 10.9 
(CH3); FTIR (thin film): ν 3027, 2973, 2927, 1604, 1496, 1554, 1390, 1296, 1168, 1103, 
1079, 965, 791 cm−1; HRMS (ESI): exact mass calculated for C22H38O4SiNa [(M+Na)+] 
417.2432, found 417.2424. 
  
 
(E)-Diethoxy(methyl)((4-methyl-1-phenylnon-4-en-3-yl)oxy)silane. The reaction 
was performed analogously; the crude product was analytically 
pure (>98% by NMR, 54 mg, 91%). 1H NMR (400 MHz, CDCl3) δ 
7.30-7.24 (m, 2H), 7.21-7.14 (m, 3H), 5.37 (t, J = 7.2 Hz, 1H), 
4.21 (t, J = 6.7 Hz, 1H), 3.78 (qd, J = 7.1, 2.8 Hz, 4H), 2.58 (m, 2H), 2.02 (m, 2H), 1.86 (m, 
2H), 1.60 (s, 3H), 1.39-1.28 (m, 4H), 1.20 (t, J = 7.0 Hz, 6H), 0.90 (m, 3H), 0.09 (s, 3H); 13C 
(101 MHz, CDCl3) δ 142.4, 136.0, 128.4, 128.3, 127.0, 125.6, 78.1, 58.22, 58.19, 37.5, 32.1, 
31.7, 27.2, 22.4, 18.24, 18.22, 14.0, 10.92, -6.44; FTIR (thin film): ṽ 3086, 3063, 3027, 
2958, 2926, 2874, 1742, 1604, 1496, 1454, 1389, 1334, 1295, 1262, 1167, 1102, 1075, 
984, 957, 888, 824, 790, 767, 748, 698 cm-1; HRMS (ESI): exact mass calculated for 
C21H36O3SiNa [(M+Na)+] 387.2326, found 387.2327. 
(E)-7-((Diethoxy(methyl)silyl)oxy)-6-methyl-9-phenylnon-5-enenitrile. Prepared 
according to the general procedure as a colorless oil (26 mg, 76 
%). 1H NMR (400 MHz, CDCl3) δ 7.31-7.25 (m, 2H), 7.21-7.15 (m, 
3H), 5.32 (t, J = 7.1 Hz, 1H), 4.23 (t, J = 6.5 Hz, 1H), 3.79 (m, 4H), 
2.59 (m, 2H), 2.35 (t, J = 7.2 Hz, 2H), 2.21 (m, 2H), 1.98-1.76 (m, 2H), 1.74 (t, J = 7.2 Hz, 
2H), 1.64 (s, 3H), 1.21 (td, J = 7.0, 0.8 Hz, 6H), 0.10 (s, 3H); 13C (101 MHz, CDCl3) δ 142.1, 
139.0, 128.34, 128.29, 125.7, 123.4, 119.6, 77.5, 58.25, 58.22, 37.4, 32.0, 26.2, 25.2, 
18.23, 16.5, 11.4, -6.5; FTIR (thin film): ṽ 3063, 3027, 2973, 2927, 2885, 2247, 1603, 
1496, 1454, 1390, 1366, 1333, 1294, 1263, 1166, 1100, 1071, 985, 956, 889, 822, 788, 
767, 750, 699 cm-1; HRMS (ESI): exact mass calculated for C21H33NO3SiNa [(M+Na)+] 
398.2122, found 398.2124. 
Ethyl (2E,5E)-4-((diethoxy(methyl)silyl)oxy)-3,5-dimethyldeca-2,5-dienoate. 
Prepared according to the general procedure as a colorless oil (28 
mg, 79 %). 1H NMR (400 MHz, CDCl3) δ 6.10 (qui, J = 1.4 Hz, 1H), 
5.51 (t, J = 7.1 Hz, 1H), 4.59 (s, 1H), 4.16 (q, J = 7.2 Hz, 2H), 3.77 (m, 4H), 2.03 (q, J = 7.1 
Hz, 2H), 1.98 (s, 3H), 1.45 (s, 3H), 1.33 (m, 4H), 1.29 (t, J = 7.1 Hz, 3H), 1.20 (td, J = 7.1, 1.9 
Hz, 6H), 0.89 (m, 3H), 0.10 (s, 3H); 13C (101 MHz, CDCl3) δ 167.1, 157.9, 133.5, 129.6, 
114.9, 81.7, 59.6, 58.37, 58.34, 31.5, 27.4, 22.3, 18.18, 15.3, 14.3, 13.9, 10.7, -6.5; FTIR 
(thin film): ṽ 2973, 2927, 2875, 1717, 1654, 1444, 1388, 1367, 1315, 1263, 1211, 1144, 
  
 
1073, 1004, 957, 887, 826, 792, 763, 734 cm-1; HRMS (ESI): exact mass calculated for 
C19H36O5SiNa [(M+Na)+] 395.2224, found 395.2224. 
(E)-((4-(Cyclohex-1-en-1-yl)-3-methylbut-3-en-2-yl)oxy)diethoxy(methyl)silane. 
Prepared according to the general procedure as a colorless oil (26 
mg, 80 %). 1H NMR (400 MHz, CDCl3) δ 5.77 (s (br), 1H), 5.58 (m, 
1H), 4.39 (q, J = 6.4 Hz, 1H), 3.79 (qd, J = 7.0, 1.5 Hz, 4H), 2.09 (m, 
4H), 1.76 (s, 3H), 1.60 (m, 4H), 1.27 (d, J = 6.3 Hz, 3H), 1.21 (t, J = 7.0 Hz, 6H), 0.11 (s, 
3H); 13C (101 MHz, CDCl3) δ 137.5, 135.0, 127.1, 126.7, 74.4, 58.23, 58.21, 29.2, 25.6, 
23.0, 22.8, 22.2, 18.24, 18.23, 13.1, -6.5; FTIR (thin film): ṽ 2973, 2927, 2835, 1650, 1439, 
1390, 1369, 1334, 1312, 1294, 1262, 1199, 1167, 1102, 1074, 991, 956, 880, 865, 825, 
779 cm-1; HRMS (ESI): exact mass calculated for C16H30O3SiNa [(M+Na)+] 321.1856, 
found 321.1854. 
(E)-((2,3-Dimethyl-6-phenylhex-3-en-2-yl)oxy)diethoxy(methyl)silane. Prepared 
according to the general procedure; the crude product was pure 
enough for further use (55 mg, 99 %). 1H NMR (400 MHz, CDCl3) δ 
7.30-7.24 (m, 2H), 7.21-7.15 (m, 3H), 5.50 (tq, J = 7.0, 1.3 Hz, 1H), 
3.77 (q, J = 7.0 Hz, 4H), 2.66 (m, 2H), 2.32 (m, 2H), 1.60 (s, 3H), 1.38 (s, 6H), 1.21 (t, J = 
7.0 Hz, 6H), 0.10 (s, 3H); 13C (101 MHz, CDCl3) δ 142.3, 141.6, 128.5, 128.2, 125.7, 121.1, 
76.6, 58.0, 35.8, 29.9, 29.2, 18.2, 12.5, -4.7; FTIR (thin film): ṽ 3086, 3063, 3027, 2974, 
2926, 2882, 1604, 1496, 1454, 1388, 1376, 1364, 1294, 1262, 1160, 1104, 1076, 1048, 
995, 815, 778, 747, 698 cm-1; HRMS (ESI): exact mass calculated for C19H32O3SiNa 
[(M+Na)+] 359.2013, found 359.2015. 
(E)-4-(3-((Diethoxy(methyl)silyl)oxy)-2,3-dimethylbut-1-en-1-yl)benzaldehyde. 
Prepared according to the general procedure as a colorless oil (20 
mg, 48 %). 1H NMR (400 MHz, CDCl3) δ 9.99 (s, 1H), 7.84 (m, 2H), 
7.40 (m, 2H), 6.67 (s, 1H), 3.82 (q, J = 7.0 Hz, 4H), 1.90 (d, J = 1.3 
Hz, 3H), 1.52 (s, 6H), 1.23 (t, J = 6.9 Hz, 6H), 0.17 (s, 3H); 13C (101 MHz, CDCl3) δ 191.9, 
147.5, 145.4, 134.2, 129.60, 129.54, 121.6, 77.0, 58.2, 29.2, 18.3, 14.6, -4.7; FTIR (thin 
film): ṽ 2975, 2927, 2881, 2825, 2734, 1720, 1698, 1649, 1602, 1566, 1507, 1482, 1443, 
1415, 1388, 1364, 1304, 1263, 1246, 1212, 1165, 1102, 1075, 1045, 1003, 981, 951, 876, 
  
 
817, 778, 732, 708, 650 cm-1; HRMS (ESI): exact mass calculated for C18H29O4Si [(M+H)+] 





(0.9 M solution in 2-Me-THF, 0.33 mL, 300 µmol) was added to a suspension of CuI 
(58.0 mg, 305 µmol) in DMF (0.50 mL) at 0 °C, the cooling bath was removed and the 
resulting dark brown solution was stirred at ambient temperature for 30 min. A solution 
of (Z)-4-(diethoxy(methyl)silyl)-1-phenylnon-4-en-3-ol (35.0 mg, 99.8 µmol) in DMF 
(0.6 mL) was added, followed  within maximum 30 seconds  by 3-chloro-2-
methylpropene (30 µL, 304 µmol). The resulting mixture was stirred for 4 hours before 
the reaction was quenched with Et3N (0.1 mL). The mixture was diluted with tert-butyl 
methyl ether (30 mL), poured on a mixture of 25% aqueous NH4OH/sat. aqueous NH4Cl 
solution (1:9, 10 mL), the phases were separated and the aqueous phase extracted with 
tert-butyl methyl ether (2 × 30 mL). The combined organic layers were dried over 
Na2SO4, filtered and concentrated under reduced pressure. Purification of the residue by 
flash chromatography (EtOAc/hexane 1:99 to 5:95; step gradient) afforded the title 
compound (34.2 mg, 85%) as colorless oil. 1H NMR (400 MHz, CDCl3): δ 7.29-7.23 (m, 
2H), 7.20-7.14 (m, 3H), 5.62 (t, J = 7.1 Hz, 1H), 4.74 (s, 1H), 4.69 (s, 1H), 4.28 (t, J = 6.0 Hz, 
1H), 3.81 (ttd, J = 7.0, 4.5, 2.3 Hz, 4H), 2.82 (d, J = 15.9 Hz, 1H), 2.71 (d, J = 15.9 Hz, 1H), 
2.75-2.54 (m, 2H), 2.02 (td, J = 7.0, 3.4 Hz, 2H), 1.88-1.80 (m, 2H), 1.72 (s, 3H), 1.40-1.29 
(m, 4H), 1.22 (td, J = 7.0, 1.6 Hz, 6H), 0.90 (t, J = 7.1 Hz, 3H), 0.11 (s, 3H); 13C NMR 
(101 MHz, CDCl3): δ 143.3 (CR4), 142.6 (CR4), 137.2 (CR4), 128.5 (CH), 128.4 (2 × CH), 
128.2 (2 × CH), 125.6 (CH), 110.9 (CH2), 75.9 (CH), 58.2 (2 × CH2), 38.2 (CH2), 35.5 (CH2), 
32.0 (CH2), 31.8 (CH2), 27.6 (CH2), 22.9 (CH3), 22.5 (CH2), 18.3 (2 × CH3), 14.0 (CH3), −6.4 
(CH3); FTIR (thin film): ν 3027, 2969, 2925, 1646, 1604, 1496, 14454, 1389, 1262, 1167, 
1077987, 957, 890, 823, 792, 767, 748 cm−1; HRMS (ESI): exact mass calculated for 
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